{
  "category": "Clinical Pathology",
  "subject": {
    "name": "Laboratory Management and Clinical Laboratory Informatics",
    "url": "https://app.pathprimer.com/curriculum/e7a2dfb9-48da-4183-b66d-8675b8e72e8b",
    "lessons": {
      "General Principles of Laboratory Management and Test Interpretation": {
        "name": "General Principles of Laboratory Management and Test Interpretation",
        "url": "https://app.pathprimer.com/lesson/accf2a35-2f9a-4c5d-be01-28ec3eac33f1",
        "topics": {
          "Reagent Rental": {
            "name": "Reagent Rental",
            "url": "https://app.pathprimer.com/document/10a22dea-f0b0-4eb3-aa70-e19f8a98458c/lesson/accf2a35-2f9a-4c5d-be01-28ec3eac33f1",
            "content": {
              "OVERVIEW": {
                "Laboratory Finances": [
                  {
                    "text": "Clinical laboratories often have difficulty raising capital required for purchasing laboratory instruments"
                  },
                  {
                    "text": "To enable use of large, expensive instruments laboratories often use reagent rentals (i.e., reagent leases)Laboratory is billed only for reagents usedPrice of reagents includes lease costs of instrumentsAt end of lease period, instruments still belong to manufacturerMajor advantage of reagent rentalLaboratory can use operational funds (as opposed to capital funds) to pay for use of instruments required to provide clinical laboratory testing",
                    "sub_points": [
                      "Laboratory is billed only for reagents used",
                      "Price of reagents includes lease costs of instruments",
                      "At end of lease period, instruments still belong to manufacturer",
                      "Major advantage of reagent rentalLaboratory can use operational funds (as opposed to capital funds) to pay for use of instruments required to provide clinical laboratory testing",
                      "Laboratory can use operational funds (as opposed to capital funds) to pay for use of instruments required to provide clinical laboratory testing"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Technology Implementation and Vendor Contracts": {
            "name": "Technology Implementation and Vendor Contracts",
            "url": "https://app.pathprimer.com/document/0e679d72-a077-4e80-9afd-e80a85cafbee/lesson/accf2a35-2f9a-4c5d-be01-28ec3eac33f1",
            "content": {
              "KEY CONCEPTS": {
                "Laboratory Finances": [
                  {
                    "text": "Main component of RFP is detailed listing of required functionality and features"
                  },
                  {
                    "text": "Many factors influence decision regarding which reference laboratory tests will be sent to reference laboratory (as opposed to in-house performance)"
                  },
                  {
                    "text": "SLA is contract that defines technical and business parameters of relationship between IT vendor and client, particularly for ASP arrangements"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Application service provider (ASP)"
                  },
                  {
                    "text": "Information technology (IT)"
                  },
                  {
                    "text": "Request for proposals (RFP)"
                  },
                  {
                    "text": "Service level agreement (SLA)"
                  }
                ]
              },
              "LABORATORY FINANCES": {
                "Request for Proposals": [
                  {
                    "text": "When making laboratory hardware/software purchase decisions, RFP should be submitted to vendorMain component is detailed listing of required functionality and featuresAsks vendor to specifyCorporate informationAbility to meet specificationsPricingOther system attributes",
                    "sub_points": [
                      "Main component is detailed listing of required functionality and featuresAsks vendor to specifyCorporate informationAbility to meet specificationsPricingOther system attributes",
                      "Asks vendor to specifyCorporate informationAbility to meet specificationsPricingOther system attributes",
                      "Corporate information",
                      "Ability to meet specifications",
                      "Pricing",
                      "Other system attributes"
                    ]
                  },
                  {
                    "text": "RFP responses become part of final contract"
                  },
                  {
                    "text": "ASP is different modelProvider delivers services remotely over network and vendor manages everything (hardware, software, security, upgrades)Comprises contractual agreementOften involves fixed subscription fee (either per transaction or flat rate)",
                    "sub_points": [
                      "Provider delivers services remotely over network and vendor manages everything (hardware, software, security, upgrades)",
                      "Comprises contractual agreement",
                      "Often involves fixed subscription fee (either per transaction or flat rate)"
                    ]
                  },
                  {
                    "text": "Reference laboratory RFPMany factors influence decision regarding which reference laboratory tests to be sent out to reference laboratory (rather than performing in-house)No single issue should be sole determining factorQuality/reliability of assaysTurnaround timesAbility to electronically interface laboratory information system with that of reference laboratoryPriceImportant to obtain input from ordering physician stakeholders at your institution when choosing reference laboratoryBenefits of electronically interfacing laboratory information system with that of reference laboratoryAvoid manual transcription errorsDecrease turnaround timesSave salary of employees who would otherwise be needed for manually transcribing results",
                    "sub_points": [
                      "Many factors influence decision regarding which reference laboratory tests to be sent out to reference laboratory (rather than performing in-house)No single issue should be sole determining factorQuality/reliability of assaysTurnaround timesAbility to electronically interface laboratory information system with that of reference laboratoryPrice",
                      "No single issue should be sole determining factorQuality/reliability of assaysTurnaround timesAbility to electronically interface laboratory information system with that of reference laboratoryPrice",
                      "Quality/reliability of assays",
                      "Turnaround times",
                      "Ability to electronically interface laboratory information system with that of reference laboratory",
                      "Price",
                      "Important to obtain input from ordering physician stakeholders at your institution when choosing reference laboratory",
                      "Benefits of electronically interfacing laboratory information system with that of reference laboratoryAvoid manual transcription errorsDecrease turnaround timesSave salary of employees who would otherwise be needed for manually transcribing results",
                      "Avoid manual transcription errors",
                      "Decrease turnaround times",
                      "Save salary of employees who would otherwise be needed for manually transcribing results"
                    ]
                  }
                ],
                "Service Level Agreement": [
                  {
                    "text": "Contract that defines technical and business parameters of relationship between IT vendor and client, particularly for ASP arrangements"
                  },
                  {
                    "text": "Key terms of SLAResponsibility (who does what)PerformanceRemediation when problems arise",
                    "sub_points": [
                      "Responsibility (who does what)",
                      "Performance",
                      "Remediation when problems arise"
                    ]
                  },
                  {
                    "text": "Quantifiable metrics need to be specifiedLack of attention to these issues can cause considerable logistical and operational problems later onSystem uptime (%)System response timeTime to address problem calls",
                    "sub_points": [
                      "Lack of attention to these issues can cause considerable logistical and operational problems later onSystem uptime (%)System response timeTime to address problem calls",
                      "System uptime (%)",
                      "System response time",
                      "Time to address problem calls"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Semivariable Cost": {
            "name": "Semivariable Cost",
            "url": "https://app.pathprimer.com/document/729faa32-1889-4401-8837-764d13e1289b/lesson/accf2a35-2f9a-4c5d-be01-28ec3eac33f1",
            "content": {
              "KEY CONCEPTS": {
                "Laboratory Finances": [
                  {
                    "text": "Costs associated with performing particular test can be fixed, variable, or semivariable"
                  }
                ]
              },
              "LABORATORY FINANCES": {
                "Semivariable Costs": [
                  {
                    "text": "Semivariable costs (also known as “step variable costs”) are expenses that vary with test volume but not in direct proportion to volume"
                  },
                  {
                    "text": "Supervisory staffing of laboratory is good exampleWhen laboratory volumes increase, given number of supervisors will be able to handle increased volume up to certain thresholdAfter this threshold is reached, additional supervisors need to be hired",
                    "sub_points": [
                      "When laboratory volumes increase, given number of supervisors will be able to handle increased volume up to certain threshold",
                      "After this threshold is reached, additional supervisors need to be hired"
                    ]
                  }
                ],
                "Fixed Costs": [
                  {
                    "text": "Fixed costs do not vary over time and do not change with sample volume"
                  }
                ],
                "Variable Costs": [
                  {
                    "text": "Variable costs vary directly and proportionally with volume of samples analyzed"
                  }
                ],
                "Examples": [
                  {
                    "text": "Types of costs associated with performing particular testFixed (e.g., purchase of equipment needed to perform test)Variable (e.g., reagents used per test)Semivariable (e.g., salaries of staff required to perform test)",
                    "sub_points": [
                      "Fixed (e.g., purchase of equipment needed to perform test)",
                      "Variable (e.g., reagents used per test)",
                      "Semivariable (e.g., salaries of staff required to perform test)"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Test Cost Classification and Calculation": {
            "name": "Test Cost Classification and Calculation",
            "url": "https://app.pathprimer.com/document/524b407d-5b13-44a7-a50d-65c3bb48cbef/lesson/accf2a35-2f9a-4c5d-be01-28ec3eac33f1",
            "content": {
              "KEY CONCEPTS": {
                "Laboratory Finances": [
                  {
                    "text": "Total cost of performing laboratory test includes labor, materials, and indirect costs"
                  },
                  {
                    "text": "Accurate cost accounting is importantAll costs must be included in cost accounting of laboratory tests",
                    "sub_points": [
                      "All costs must be included in cost accounting of laboratory tests"
                    ]
                  }
                ]
              },
              "LABORATORY FINANCES": {
                "Cost Accounting": [
                  {
                    "text": "Total cost of performing laboratory test includes labor, materials, and indirect costsDirect costsCan easily be traced directly to end producte.g., reagents, consumables, hands-on technologist timeIndirect costs (a.k.a. overhead)Not directly related to billable test, but necessary for its productione.g., proficiency testing, utility expensesVariable costsVary directly and proportionally with volume of samples analyzede.g., reagents used per testFixed costsDo not vary over time and do not change with sample volumee.g., purchase of equipment needed to perform testSemi-variable costs (a.k.a. step variable costs)Vary with test volume but not in direct proportion to volumee.g., supervisory staffing of laboratoryWhen laboratory volumes increase, a given number of supervisors can handle increased volume up to certain thresholdWhen threshold is reached, additional supervisors must be hired",
                    "sub_points": [
                      "Direct costsCan easily be traced directly to end producte.g., reagents, consumables, hands-on technologist time",
                      "Can easily be traced directly to end product",
                      "e.g., reagents, consumables, hands-on technologist time",
                      "Indirect costs (a.k.a. overhead)Not directly related to billable test, but necessary for its productione.g., proficiency testing, utility expenses",
                      "Not directly related to billable test, but necessary for its production",
                      "e.g., proficiency testing, utility expenses",
                      "Variable costsVary directly and proportionally with volume of samples analyzede.g., reagents used per test",
                      "Vary directly and proportionally with volume of samples analyzed",
                      "e.g., reagents used per test",
                      "Fixed costsDo not vary over time and do not change with sample volumee.g., purchase of equipment needed to perform test",
                      "Do not vary over time and do not change with sample volume",
                      "e.g., purchase of equipment needed to perform test",
                      "Semi-variable costs (a.k.a. step variable costs)Vary with test volume but not in direct proportion to volumee.g., supervisory staffing of laboratoryWhen laboratory volumes increase, a given number of supervisors can handle increased volume up to certain thresholdWhen threshold is reached, additional supervisors must be hired",
                      "Vary with test volume but not in direct proportion to volume",
                      "e.g., supervisory staffing of laboratoryWhen laboratory volumes increase, a given number of supervisors can handle increased volume up to certain thresholdWhen threshold is reached, additional supervisors must be hired",
                      "When laboratory volumes increase, a given number of supervisors can handle increased volume up to certain threshold",
                      "When threshold is reached, additional supervisors must be hired"
                    ]
                  },
                  {
                    "text": "Accurate cost accounting is importantAll costs must be included in cost accounting of laboratory testsAllows for accurate pricing of laboratory servicesAllows laboratory to make informed decisions about whether to perform nonurgent testing in-house or to send those samples to reference laboratory",
                    "sub_points": [
                      "All costs must be included in cost accounting of laboratory testsAllows for accurate pricing of laboratory servicesAllows laboratory to make informed decisions about whether to perform nonurgent testing in-house or to send those samples to reference laboratory",
                      "Allows for accurate pricing of laboratory services",
                      "Allows laboratory to make informed decisions about whether to perform nonurgent testing in-house or to send those samples to reference laboratory"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Turnaround Time": {
            "name": "Turnaround Time",
            "url": "https://app.pathprimer.com/document/355c1654-23b7-49cf-904f-a928fd1b49b3/lesson/accf2a35-2f9a-4c5d-be01-28ec3eac33f1",
            "content": {
              "KEY CONCEPTS": {
                "Workflow": [
                  {
                    "text": "Total turnaround time for laboratory sample consists of the sum of preanalytical, analytical, and postanalytical intervals"
                  },
                  {
                    "text": "Possible interventions for decreasing preanalytical turnaround interval include electronic order entry, laboratory automation, additional laboratory staff, and redesign of laboratory workflow"
                  }
                ]
              },
              "WORKFLOW": {
                "Total Turnaround Time Definition": [
                  {
                    "text": "Total turnaround time for laboratory sample consists of sum of preanalytical, analytical, and postanalytical intervalsPreanalytical interval = time from ordering of test to beginning of sample analysisAnalytical interval = time needed for analysisPostanalytical interval = time from completion of analysis to notification of ordering clinician",
                    "sub_points": [
                      "Preanalytical interval = time from ordering of test to beginning of sample analysis",
                      "Analytical interval = time needed for analysis",
                      "Postanalytical interval = time from completion of analysis to notification of ordering clinician"
                    ]
                  },
                  {
                    "text": "Inclusion of all relevant components of total turnaround time is important for laboratory turnaround reports"
                  }
                ],
                "Turnaround Time and Workflow Redesign": [
                  {
                    "text": "Preanalytical turnaround time interval includes following time intervalsFrom ordering to collectionFrom collection to receipt in laboratoryFrom receipt to accessioningFrom accessioning to completion of all necessary preanalytical steps (e.g., centrifugation, aliquoting)Also includes transport times within and between laboratory sections",
                    "sub_points": [
                      "From ordering to collection",
                      "From collection to receipt in laboratory",
                      "From receipt to accessioning",
                      "From accessioning to completion of all necessary preanalytical steps (e.g., centrifugation, aliquoting)",
                      "Also includes transport times within and between laboratory sections"
                    ]
                  },
                  {
                    "text": "Possible interventions for decreasing preanalytical turnaround intervalElectronic order entryRequires significant financial investment as well as cooperation from health care providersLaboratory automationAdditional laboratory staffRedesign of laboratory workflow",
                    "sub_points": [
                      "Electronic order entryRequires significant financial investment as well as cooperation from health care providers",
                      "Requires significant financial investment as well as cooperation from health care providers",
                      "Laboratory automation",
                      "Additional laboratory staff",
                      "Redesign of laboratory workflow"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Clinical Laboratory Salary Expenses": {
            "name": "Clinical Laboratory Salary Expenses",
            "url": "https://app.pathprimer.com/document/289aee47-42d1-46e6-9987-0127247ead85/lesson/accf2a35-2f9a-4c5d-be01-28ec3eac33f1",
            "content": {
              "LABORATORY FINANCES": {
                "Salary Expenses Overview": [
                  {
                    "text": "Total salary expenses (including fringe benefits) account for 60-80% of typical clinical laboratory budget"
                  },
                  {
                    "text": "Fringe benefits (Social Security, health insurance, pension plans, etc.) can represent additional 16-28% expense above salary base"
                  }
                ],
                "Salary Expenses Management": [
                  {
                    "text": "Because salary expenses are generally fixed, it is important to strive for efficiency, productivity, and economies of scale"
                  },
                  {
                    "text": "Costs associated with hiring staffRecruitmentInterviewSelection process",
                    "sub_points": [
                      "Recruitment",
                      "Interview",
                      "Selection process"
                    ]
                  },
                  {
                    "text": "Costs associated with new employeeOrientationTraining",
                    "sub_points": [
                      "Orientation",
                      "Training"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Current Procedural Terminology (CPT) Unbundling Panels": {
            "name": "Current Procedural Terminology (CPT) Unbundling Panels",
            "url": "https://app.pathprimer.com/document/f7284b2d-497f-41ef-a20b-bdfd14059292/lesson/accf2a35-2f9a-4c5d-be01-28ec3eac33f1",
            "content": {
              "KEY CONCEPTS": {
                "Laboratory Finances": [
                  {
                    "text": "CPT codes serve to identify the laboratory test performed, as well as most medical services"
                  },
                  {
                    "text": "Coding for each individual assay in a panel (i.e., unbundling), as opposed to coding for the entire panel, may be considered fraud"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "American Medical Association (AMA)"
                  },
                  {
                    "text": "Current procedural terminology (CPT)"
                  }
                ]
              },
              "LABORATORY FINANCES": {
                "CPT Codes": [
                  {
                    "text": "CPT codes serve to identify the laboratory test performed, as well as most medical services"
                  },
                  {
                    "text": "Assigned by the AMAReviewed and updated annually to remain current with changes in technology and medical practice",
                    "sub_points": [
                      "Reviewed and updated annually to remain current with changes in technology and medical practice"
                    ]
                  },
                  {
                    "text": "Specific CPT codes exist for each of 10 frequently used panelsBasic metabolic panel (2 types)Calcium, ionizedCalcium, totalGeneral health panelElectrolyte panelComprehensive metabolic panelObstetrical panelLipid panelRenal function panelAcute hepatitis panelHepatic function panel",
                    "sub_points": [
                      "Basic metabolic panel (2 types)Calcium, ionizedCalcium, total",
                      "Calcium, ionized",
                      "Calcium, total",
                      "General health panel",
                      "Electrolyte panel",
                      "Comprehensive metabolic panel",
                      "Obstetrical panel",
                      "Lipid panel",
                      "Renal function panel",
                      "Acute hepatitis panel",
                      "Hepatic function panel"
                    ]
                  }
                ],
                "Unbundling CPT Codes": [
                  {
                    "text": "Coding for each individual assay in a panel (i.e., unbundling), as opposed to coding for the entire panel, may be considered fraud if intent to defraud CMS can be provedCharges are filed under False Claims Act",
                    "sub_points": [
                      "Charges are filed under False Claims Act"
                    ]
                  },
                  {
                    "text": "Reimbursement for a panel is less than for the sum total of reimbursement for its components"
                  },
                  {
                    "text": "Rules apply equally to inpatients and outpatients"
                  },
                  {
                    "text": "Resources for information about code bundling include CPT Assistant, CPT Manual, and National Correct Coding Initiative"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Laboratory Personnel Requirements": {
            "name": "Laboratory Personnel Requirements",
            "url": "https://app.pathprimer.com/document/eab40100-d43d-4ffe-9d48-96a731003b22/lesson/accf2a35-2f9a-4c5d-be01-28ec3eac33f1",
            "content": {
              "KEY CONCEPTS": {
                "Human Resources": [
                  {
                    "text": "Laboratory directorResponsible for analytical performance of all assays and determining qualifications of individuals performing tests and reporting results",
                    "sub_points": [
                      "Responsible for analytical performance of all assays and determining qualifications of individuals performing tests and reporting results"
                    ]
                  },
                  {
                    "text": "Testing personnelResponsible for specimen processing, test performance, and test results reporting",
                    "sub_points": [
                      "Responsible for specimen processing, test performance, and test results reporting"
                    ]
                  },
                  {
                    "text": "Technical consultantResponsible for technical and scientific oversight of testing",
                    "sub_points": [
                      "Responsible for technical and scientific oversight of testing"
                    ]
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Continuing medical education (CME)"
                  }
                ]
              },
              "HUMAN RESOURCES": {
                "Laboratory Requirements": [
                  {
                    "text": "Laboratories performing under certificate of waiver not required to have laboratory director"
                  },
                  {
                    "text": "Laboratories performing moderately complex testing required to have laboratory director"
                  }
                ],
                "Laboratory Director": [
                  {
                    "text": "Minimum qualificationsPhysician with 1 year of experience directing/supervising nonwaived laboratory, along with 20 CME credits in laboratory practicePerson with bachelor's degree and 2 years' laboratory training/experience, plus 2 years' supervisory experience in nonwaived testingDepending on education and experience, laboratory director could qualify for all other positions",
                    "sub_points": [
                      "Physician with 1 year of experience directing/supervising nonwaived laboratory, along with 20 CME credits in laboratory practice",
                      "Person with bachelor's degree and 2 years' laboratory training/experience, plus 2 years' supervisory experience in nonwaived testing",
                      "Depending on education and experience, laboratory director could qualify for all other positions"
                    ]
                  },
                  {
                    "text": "ResponsibilitiesOverall management and direction of laboratoryAnalytical performance of all assaysDetermining qualifications of individuals performing tests and reporting results",
                    "sub_points": [
                      "Overall management and direction of laboratory",
                      "Analytical performance of all assays",
                      "Determining qualifications of individuals performing tests and reporting results"
                    ]
                  }
                ],
                "Testing Personnel": [
                  {
                    "text": "Minimum qualificationsHigh school diploma or equivalentTraining for specific testing performed",
                    "sub_points": [
                      "High school diploma or equivalent",
                      "Training for specific testing performed"
                    ]
                  },
                  {
                    "text": "ResponsibilitiesSpecimen processingTest performanceTest results reporting",
                    "sub_points": [
                      "Specimen processing",
                      "Test performance",
                      "Test results reporting"
                    ]
                  }
                ],
                "Technical Consultant": [
                  {
                    "text": "Minimum qualificationsBachelor's degree with 2 years' laboratory training or experience in nonwaived testing",
                    "sub_points": [
                      "Bachelor's degree with 2 years' laboratory training or experience in nonwaived testing"
                    ]
                  },
                  {
                    "text": "ResponsibilitiesTechnical and scientific oversight of testing",
                    "sub_points": [
                      "Technical and scientific oversight of testing"
                    ]
                  }
                ],
                "Clinical Consultant": [
                  {
                    "text": "Minimum qualificationsDoctoral degree with board certification",
                    "sub_points": [
                      "Doctoral degree with board certification"
                    ]
                  },
                  {
                    "text": "ResponsibilitiesClinical consultation",
                    "sub_points": [
                      "Clinical consultation"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Break-Even Analysis": {
            "name": "Break-Even Analysis",
            "url": "https://app.pathprimer.com/document/fc638a53-b968-43bc-82e7-276c1e54d0c3/lesson/accf2a35-2f9a-4c5d-be01-28ec3eac33f1",
            "content": {
              "TERMINOLOGY": {
                "Definitions": [
                  {
                    "text": "Break-even analysis: Process of calculating sales needed to cover costs so that there is zero profit or loss"
                  }
                ]
              },
              "LABORATORY FINANCES": {
                "Details": [
                  {
                    "text": "In the laboratory, break-even analysis can be used as screening tool to determine whether bringing new assay in-house makes financial senseNot only determining factor in decision regarding whether a laboratory test should be performed in-houseClinical needs and physician and patient satisfaction can override break-even analysis",
                    "sub_points": [
                      "Not only determining factor in decision regarding whether a laboratory test should be performed in-house",
                      "Clinical needs and physician and patient satisfaction can override break-even analysis"
                    ]
                  },
                  {
                    "text": "Usually based on assumption that selling price of a product (e.g., laboratory test) is constant"
                  },
                  {
                    "text": "Can be used to help determine price of a new assayBecause most insurance reimbursement rates are fixed, prices charged by laboratory are less important than reimbursement rates",
                    "sub_points": [
                      "Because most insurance reimbursement rates are fixed, prices charged by laboratory are less important than reimbursement rates"
                    ]
                  },
                  {
                    "text": "Break-even analysis is important for both for-profit and not-for-profit laboratories"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Diagnosis-Related Groups": {
            "name": "Diagnosis-Related Groups",
            "url": "https://app.pathprimer.com/document/dca7086d-9e9d-4f7f-9f89-bdd4678ea90a/lesson/accf2a35-2f9a-4c5d-be01-28ec3eac33f1",
            "content": {
              "KEY CONCEPTS": {
                "Laboratory Finances": [
                  {
                    "text": "DRGs only used to reimburse hospital costs for Medicare inpatients"
                  },
                  {
                    "text": "In DRG-based systems, hospitals receive lump sum for treating each patient"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Diagnosis-related group (DRG)"
                  }
                ]
              },
              "LABORATORY FINANCES": {
                "Details": [
                  {
                    "text": "Prior to 1983, hospitals and freestanding laboratories billed insurers or private parties on fee-for-service basisAfter that time, Medicare started reimbursing hospitals for inpatient treatment based on DRGs",
                    "sub_points": [
                      "After that time, Medicare started reimbursing hospitals for inpatient treatment based on DRGs"
                    ]
                  },
                  {
                    "text": "DRGs only used to reimburse hospital costs for Medicare inpatients"
                  },
                  {
                    "text": "DRGs NOT usedTo reimburse hospitals for services provided to outpatientsTo reimburse physicians for their services",
                    "sub_points": [
                      "To reimburse hospitals for services provided to outpatients",
                      "To reimburse physicians for their services"
                    ]
                  },
                  {
                    "text": "Each DRG assigned a weight based on the followingSeverity of diagnosisTypes of procedures performedPresence of comorbid conditions or complications",
                    "sub_points": [
                      "Severity of diagnosis",
                      "Types of procedures performed",
                      "Presence of comorbid conditions or complications"
                    ]
                  },
                  {
                    "text": "Hospitals reimbursed for each DRG by rate determined with reference to the followingType of hospitalHospital settingHospital location",
                    "sub_points": [
                      "Type of hospital",
                      "Hospital setting",
                      "Hospital location"
                    ]
                  },
                  {
                    "text": "In DRG-based systems, hospitals receive lump sum for treating each patientNo additional revenue provided for performing more laboratory tests for that patient",
                    "sub_points": [
                      "No additional revenue provided for performing more laboratory tests for that patient"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Blood Collection Tubes": {
            "name": "Blood Collection Tubes",
            "url": "https://app.pathprimer.com/document/c97f7d2b-4511-4d21-9d93-36bd7e954c9f/lesson/accf2a35-2f9a-4c5d-be01-28ec3eac33f1",
            "content": {
              "KEY CONCEPTS": {
                "Specimens": [
                  {
                    "text": "Depending on the assay, certain additives must be present in collection tubes to produce the best outcomes"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Serum separator tube (SST)"
                  },
                  {
                    "text": "Ethylenediaminetetraacetic acid (EDTA)"
                  }
                ]
              },
              "SPECIMENS": {
                "Additives": [
                  {
                    "text": "Depending on the assay, certain additives must be present in collection tubes to produce the best outcomesLavender-top tubes contain EDTA, which chelates (binds) calcium and prevents clotting of specimenGreen-top tubes contain heparin, which inactivates thrombin and activated factor XAdvantage over EDTA is that it does not affect levels of ions such as calciumGray-top tubes contain potassium oxalate/sodium fluoride, which inhibits glycolysis",
                    "sub_points": [
                      "Lavender-top tubes contain EDTA, which chelates (binds) calcium and prevents clotting of specimen",
                      "Green-top tubes contain heparin, which inactivates thrombin and activated factor XAdvantage over EDTA is that it does not affect levels of ions such as calcium",
                      "Advantage over EDTA is that it does not affect levels of ions such as calcium",
                      "Gray-top tubes contain potassium oxalate/sodium fluoride, which inhibits glycolysis"
                    ]
                  }
                ],
                "Serum Separator Tubes": [
                  {
                    "text": "Mainly used in clinical chemistry for routine assays"
                  },
                  {
                    "text": "Contain gel that, during centrifugation, localizes between packed cells and top serum layer, separating themGel separator in SSTs can absorb certain drugs and interfere with immunologic reactionsDo not use for therapeutic drug monitoring (e.g., phenytoin, phenobarbital, lidocaine, quinidine, carbamazepine)Do not use for blood bank serology or testing using immunologic methods",
                    "sub_points": [
                      "Gel separator in SSTs can absorb certain drugs and interfere with immunologic reactionsDo not use for therapeutic drug monitoring (e.g., phenytoin, phenobarbital, lidocaine, quinidine, carbamazepine)Do not use for blood bank serology or testing using immunologic methods",
                      "Do not use for therapeutic drug monitoring (e.g., phenytoin, phenobarbital, lidocaine, quinidine, carbamazepine)",
                      "Do not use for blood bank serology or testing using immunologic methods"
                    ]
                  },
                  {
                    "text": "Some reports indicate that SSTs can interfere with endocrine testing, thus not first choice for collecting samples for endocrine assays"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Precollection Variables": {
            "name": "Precollection Variables",
            "url": "https://app.pathprimer.com/document/1fb4f36e-e174-4718-9211-285165b805f8/lesson/accf2a35-2f9a-4c5d-be01-28ec3eac33f1",
            "content": {
              "KEY CONCEPTS": {
                "Specimens": [
                  {
                    "text": "Precollection variables can affect laboratory test values"
                  }
                ]
              },
              "SPECIMENS": {
                "Collection": [
                  {
                    "text": "Precollection variables can affect laboratory test values"
                  },
                  {
                    "text": "Care should be taken to minimize physiologic factors related to activities that might influence laboratory determination"
                  }
                ],
                "Posture": [
                  {
                    "text": "Standing vs. supineStanding leads to increased venous pressure in lower parts of body, increased capillary pressure and, therefore, filtration of plasma into interstitial spaceTherefore causes increase in intravascular concentration of protein molecules, which do not easily pass the capillary endotheliumHence, ambulatory patients have higher serum albumin levels than bed-bound patientsFor the same reason, substances that are partly or entirely protein-bound (e.g., drugs, cholesterol, hormones, some metal ions) are also higher in blood, serum, and plasma of ambulatory patientsIn this setting (i.e., standing), serum levels of ionized calcium less affected than total calcium",
                    "sub_points": [
                      "Standing leads to increased venous pressure in lower parts of body, increased capillary pressure and, therefore, filtration of plasma into interstitial spaceTherefore causes increase in intravascular concentration of protein molecules, which do not easily pass the capillary endotheliumHence, ambulatory patients have higher serum albumin levels than bed-bound patientsFor the same reason, substances that are partly or entirely protein-bound (e.g., drugs, cholesterol, hormones, some metal ions) are also higher in blood, serum, and plasma of ambulatory patients",
                      "Therefore causes increase in intravascular concentration of protein molecules, which do not easily pass the capillary endothelium",
                      "Hence, ambulatory patients have higher serum albumin levels than bed-bound patients",
                      "For the same reason, substances that are partly or entirely protein-bound (e.g., drugs, cholesterol, hormones, some metal ions) are also higher in blood, serum, and plasma of ambulatory patients",
                      "In this setting (i.e., standing), serum levels of ionized calcium less affected than total calcium"
                    ]
                  }
                ],
                "Tourniquet Application": [
                  {
                    "text": "Prolonged application of tourniquet before venipunctureCauses hemoconcentrationHemoconcentration causes increase in serum and plasma levels of total protein, iron, lipid, and cholesterolCauses anaerobic glycolysisIncreases plasma lactate and decreases pH",
                    "sub_points": [
                      "Causes hemoconcentrationHemoconcentration causes increase in serum and plasma levels of total protein, iron, lipid, and cholesterol",
                      "Hemoconcentration causes increase in serum and plasma levels of total protein, iron, lipid, and cholesterol",
                      "Causes anaerobic glycolysisIncreases plasma lactate and decreases pH",
                      "Increases plasma lactate and decreases pH"
                    ]
                  },
                  {
                    "text": "Repeated fist clenching during phlebotomyCan cause 1-2 mEq/L increase in serum potassium levels",
                    "sub_points": [
                      "Can cause 1-2 mEq/L increase in serum potassium levels"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Optical Interferences in Spectrophotometry": {
            "name": "Optical Interferences in Spectrophotometry",
            "url": "https://app.pathprimer.com/document/b3210c21-faf0-4779-a987-4bd418d33438/lesson/accf2a35-2f9a-4c5d-be01-28ec3eac33f1",
            "content": {
              "PROCESSING": {
                "Interference": [
                  {
                    "text": "Most common substances to cause optical interferences in spectrophotometric assaysBilirubinDue to high light absorbance (between 340 and 500 nm)HemoglobinDue to high light absorbance, particularly surrounding Soret band at 412 nmLipidsBy scattering light and thereby blocking light transmissionInterference due to lipemia can be reduced by ultracentrifugation of sample",
                    "sub_points": [
                      "BilirubinDue to high light absorbance (between 340 and 500 nm)",
                      "Due to high light absorbance (between 340 and 500 nm)",
                      "HemoglobinDue to high light absorbance, particularly surrounding Soret band at 412 nm",
                      "Due to high light absorbance, particularly surrounding Soret band at 412 nm",
                      "LipidsBy scattering light and thereby blocking light transmissionInterference due to lipemia can be reduced by ultracentrifugation of sample",
                      "By scattering light and thereby blocking light transmission",
                      "Interference due to lipemia can be reduced by ultracentrifugation of sample"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Preanalysis High Errors": {
            "name": "Preanalysis High Errors",
            "url": "https://app.pathprimer.com/document/576abfc1-4ffa-49ac-8eac-52671fcd5763/lesson/accf2a35-2f9a-4c5d-be01-28ec3eac33f1",
            "content": {
              "SAFETY": {
                "Errors": [
                  {
                    "text": "Based on strong evidence that medical errors are significant causes of morbidity and mortality, Joint Commission and other regulatory agencies emphasize avoidance of errors in all aspects of patient care, including laboratory testing"
                  },
                  {
                    "text": "Errors that affect laboratory results can occur in different phasesPreanalyticalMost studies indicate that majority of errors (~ 60%) occur in this phasee.g., inappropriate test selection; incorrect patient identification; incorrect storage; and sample defects (low-quantity, hemolyzed, clotted samples)Analytical~ 15% of errors occur in this phasee.g., systematic and random error (interferences, technologist factors)Postanalytical~ 20% of errors occur in this phasee.g., delayed reporting, errors in reports (transcription/proofreading), and incorrect responses to information",
                    "sub_points": [
                      "PreanalyticalMost studies indicate that majority of errors (~ 60%) occur in this phasee.g., inappropriate test selection; incorrect patient identification; incorrect storage; and sample defects (low-quantity, hemolyzed, clotted samples)",
                      "Most studies indicate that majority of errors (~ 60%) occur in this phase",
                      "e.g., inappropriate test selection; incorrect patient identification; incorrect storage; and sample defects (low-quantity, hemolyzed, clotted samples)",
                      "Analytical~ 15% of errors occur in this phasee.g., systematic and random error (interferences, technologist factors)",
                      "~ 15% of errors occur in this phase",
                      "e.g., systematic and random error (interferences, technologist factors)",
                      "Postanalytical~ 20% of errors occur in this phasee.g., delayed reporting, errors in reports (transcription/proofreading), and incorrect responses to information",
                      "~ 20% of errors occur in this phase",
                      "e.g., delayed reporting, errors in reports (transcription/proofreading), and incorrect responses to information"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Strategic Planning": {
            "name": "Strategic Planning",
            "url": "https://app.pathprimer.com/document/93f142cc-d71a-4415-be62-a28dbc7f57ac/lesson/accf2a35-2f9a-4c5d-be01-28ec3eac33f1",
            "content": {
              "TERMINOLOGY": {
                "Definitions": [
                  {
                    "text": "Strategic planning: Process by which high-level decisions are madeDecide on organizational objectives (modify existing objectives, as appropriate)Allocate resources to obtain these objectivesEstablish policies that govern acquisition, use, and disposition of these resourcesUsually based on long-term projections and a global view that can impact all levels of laboratory operationsDifferent from ﻿tactical planningGenerally not result of single individual's creation, but rather derived by committee",
                    "sub_points": [
                      "Decide on organizational objectives (modify existing objectives, as appropriate)",
                      "Allocate resources to obtain these objectives",
                      "Establish policies that govern acquisition, use, and disposition of these resources",
                      "Usually based on long-term projections and a global view that can impact all levels of laboratory operations",
                      "Different from ﻿tactical planning",
                      "Generally not result of single individual's creation, but rather derived by committee"
                    ]
                  },
                  {
                    "text": "Tactical planning: Detailed day-to-day operations needed to meet immediate needs of laboratoryWork toward long-terms strategic goals",
                    "sub_points": [
                      "Work toward long-terms strategic goals"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "In Vitro and In Vivo Interferences": {
            "name": "In Vitro and In Vivo Interferences",
            "url": "https://app.pathprimer.com/document/5ec9cb40-fa15-4771-bc33-d324c7d3d733/lesson/accf2a35-2f9a-4c5d-be01-28ec3eac33f1",
            "content": {
              "PROCESSING": {
                "Interference": [
                  {
                    "text": "Smoking is common ﻿in vivo interference in laboratory testingHigh blood carboxyhemoglobin, plasma catecholamines, serum cortisolChanges: Decreased eosinophils and increased neutrophils, monocytes, plasma free fatty acidsImmune response changes: Lower IgA, IgG, IgM and higher IgESubstantially lower vitamin B12",
                    "sub_points": [
                      "High blood carboxyhemoglobin, plasma catecholamines, serum cortisol",
                      "Changes: Decreased eosinophils and increased neutrophils, monocytes, plasma free fatty acids",
                      "Immune response changes: Lower IgA, IgG, IgM and higher IgE",
                      "Substantially lower vitamin B12"
                    ]
                  },
                  {
                    "text": "In vitro interferences in laboratory testing commonly associated with collectionHemolysisCausesShear forces on red blood cellsWhen there is problem finding vein for phlebotomyUsing too small of needlePulling syringe plunger too fast and expelling blood too vigorouslyPresent when serum or plasma layer is pink﻿Can cause changes in serum concentration of various red blood cell constituentsPseudohyperkalemia can occur in patients with high number of blasts in their blood due to their fragility and lysis during collection",
                    "sub_points": [
                      "HemolysisCausesShear forces on red blood cellsWhen there is problem finding vein for phlebotomyUsing too small of needlePulling syringe plunger too fast and expelling blood too vigorouslyPresent when serum or plasma layer is pink﻿Can cause changes in serum concentration of various red blood cell constituents",
                      "CausesShear forces on red blood cellsWhen there is problem finding vein for phlebotomyUsing too small of needlePulling syringe plunger too fast and expelling blood too vigorously",
                      "Shear forces on red blood cells",
                      "When there is problem finding vein for phlebotomy",
                      "Using too small of needle",
                      "Pulling syringe plunger too fast and expelling blood too vigorously",
                      "Present when serum or plasma layer is pink﻿",
                      "Can cause changes in serum concentration of various red blood cell constituents",
                      "Pseudohyperkalemia can occur in patients with high number of blasts in their blood due to their fragility and lysis during collection"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          }
        }
      },
      "Laboratory Management Statistics": {
        "name": "Laboratory Management Statistics",
        "url": "https://app.pathprimer.com/lesson/6792c0aa-9fc5-4143-ac04-406d235d317d",
        "topics": {
          "Sensitivity and Specificity": {
            "name": "Sensitivity and Specificity",
            "url": "https://app.pathprimer.com/document/1c4b5ee6-8d3c-4c53-8394-3336d3f4b0e8/lesson/6792c0aa-9fc5-4143-ac04-406d235d317d",
            "content": {
              "LABORATORY STATISTICS": {
                "Key Concepts": [
                  {
                    "text": "Sensitivity and specificityMeasures of diagnostic accuracy of a testIndicators of a test's ability to distinguish between disease and absence of disease at a chosen cutoffNOT fixed characteristics of a testMust be calculated from a different 2 x 2 table for each cutoff chosen",
                    "sub_points": [
                      "Measures of diagnostic accuracy of a test",
                      "Indicators of a test's ability to distinguish between disease and absence of disease at a chosen cutoff",
                      "NOT fixed characteristics of a testMust be calculated from a different 2 x 2 table for each cutoff chosen",
                      "Must be calculated from a different 2 x 2 table for each cutoff chosen"
                    ]
                  }
                ],
                "Sensitivity": [
                  {
                    "text": "Ability of a test to detect the disease when presentExpressed as the proportion of persons with the disease in whom the test is positiveCalculationSensitivity (%) = 100 x (# of true positive patients / ([# of true positive patients] + [# of false negative patients])﻿)",
                    "sub_points": [
                      "Expressed as the proportion of persons with the disease in whom the test is positive",
                      "CalculationSensitivity (%) = 100 x (# of true positive patients / ([# of true positive patients] + [# of false negative patients])﻿)",
                      "Sensitivity (%) = 100 x (# of true positive patients / ([# of true positive patients] + [# of false negative patients])﻿)"
                    ]
                  }
                ],
                "Specificity": [
                  {
                    "text": "Ability of a test to detect absence of diseaseExpressed as the proportion of persons without the disease in whom the test is negativeCalculationSpecificity (%) = 100 x (# of true negative patients / ([# of true negative patients] + [# of false positive patients]))",
                    "sub_points": [
                      "Expressed as the proportion of persons without the disease in whom the test is negative",
                      "CalculationSpecificity (%) = 100 x (# of true negative patients / ([# of true negative patients] + [# of false positive patients]))",
                      "Specificity (%) = 100 x (# of true negative patients / ([# of true negative patients] + [# of false positive patients]))"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Accuracy vs. Precision": {
            "name": "Accuracy vs. Precision",
            "url": "https://app.pathprimer.com/document/92876367-dc32-48a3-8c2d-f43f6cc040a3/lesson/6792c0aa-9fc5-4143-ac04-406d235d317d",
            "content": {
              "KEY CONCEPTS": {
                "Terminology": [
                  {
                    "text": "Accuracy: Ability of test to correctly detect and quantify analyte (i.e., obtain correct answer)"
                  },
                  {
                    "text": "Precision: Otherwise known as reproducibility of test; expressed by using CV"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Coefficient of variation (CV)"
                  },
                  {
                    "text": "Standard deviation (SD)"
                  },
                  {
                    "text": "Standard Deviation Index (SDI)"
                  }
                ],
                "Definitions": [
                  {
                    "text": "AccuracyAbility of test to correctly detect and quantify analyte (i.e., obtain correct answer)Accomplished by assaying patient specimens or interlaboratory survey materials with known valuesAccuracy can also be assessed by comparing test results from one method with results from reference method, using same samples\"Analytical range\" of assay refers to interval between highest and lowest concentrations of analyte in which precision, accuracy, and linearity have been demonstrated to be acceptable\"Limit of detection\" is lowest concentration of analyte that can be reliably detectedAccuracy of any assay depends heavily on calibratorsHow they are originally constitutedHow they remain stable over timeHow they compare with calibrators from other vendorsBest situation is to have assay calibrated against internationally distributed standards",
                    "sub_points": [
                      "Ability of test to correctly detect and quantify analyte (i.e., obtain correct answer)",
                      "Accomplished by assaying patient specimens or interlaboratory survey materials with known values",
                      "Accuracy can also be assessed by comparing test results from one method with results from reference method, using same samples",
                      "\"Analytical range\" of assay refers to interval between highest and lowest concentrations of analyte in which precision, accuracy, and linearity have been demonstrated to be acceptable",
                      "\"Limit of detection\" is lowest concentration of analyte that can be reliably detected",
                      "Accuracy of any assay depends heavily on calibratorsHow they are originally constitutedHow they remain stable over timeHow they compare with calibrators from other vendorsBest situation is to have assay calibrated against internationally distributed standards",
                      "How they are originally constituted",
                      "How they remain stable over time",
                      "How they compare with calibrators from other vendors",
                      "Best situation is to have assay calibrated against internationally distributed standards"
                    ]
                  },
                  {
                    "text": "PrecisionOtherwise known as reproducibility of testExpressed by using CVDetermining precision is accomplished by repeating test multiple times using same sample and determining range of variationCV (%) = 100 × [SD/mean]SD is measure of dispersion from mean in Gaussian normal distributionSDI is distance individual data point is away from mean value divided by SDOne common use of SDI is to standardize performance of laboratory with regard to proficiency testing performance of all laboratoriesSDI of ±2.0 is sometimes used as cutoff to identify labs with unacceptable performance on proficiency testing sampleSDI = (lab result - peer group mean)/peer group SDCV of test can vary over assay’s analytical rangeShould be determined at low-range, mid-range, and high-range values“Within-run” or “intra-assay” CV is determined by repeating test using same sample on 1 day, typically during 1 run“Between-run” or “interassay” CV is determined by comparing results obtained with same assay on different days using same sampleTypically, within-run CV is smaller than between-run CV",
                    "sub_points": [
                      "Otherwise known as reproducibility of test",
                      "Expressed by using CVDetermining precision is accomplished by repeating test multiple times using same sample and determining range of variationCV (%) = 100 × [SD/mean]SD is measure of dispersion from mean in Gaussian normal distributionSDI is distance individual data point is away from mean value divided by SDOne common use of SDI is to standardize performance of laboratory with regard to proficiency testing performance of all laboratoriesSDI of ±2.0 is sometimes used as cutoff to identify labs with unacceptable performance on proficiency testing sampleSDI = (lab result - peer group mean)/peer group SDCV of test can vary over assay’s analytical rangeShould be determined at low-range, mid-range, and high-range values“Within-run” or “intra-assay” CV is determined by repeating test using same sample on 1 day, typically during 1 run“Between-run” or “interassay” CV is determined by comparing results obtained with same assay on different days using same sampleTypically, within-run CV is smaller than between-run CV",
                      "Determining precision is accomplished by repeating test multiple times using same sample and determining range of variation",
                      "CV (%) = 100 × [SD/mean]",
                      "SD is measure of dispersion from mean in Gaussian normal distribution",
                      "SDI is distance individual data point is away from mean value divided by SDOne common use of SDI is to standardize performance of laboratory with regard to proficiency testing performance of all laboratoriesSDI of ±2.0 is sometimes used as cutoff to identify labs with unacceptable performance on proficiency testing sampleSDI = (lab result - peer group mean)/peer group SD",
                      "One common use of SDI is to standardize performance of laboratory with regard to proficiency testing performance of all laboratories",
                      "SDI of ±2.0 is sometimes used as cutoff to identify labs with unacceptable performance on proficiency testing sample",
                      "SDI = (lab result - peer group mean)/peer group SD",
                      "CV of test can vary over assay’s analytical rangeShould be determined at low-range, mid-range, and high-range values“Within-run” or “intra-assay” CV is determined by repeating test using same sample on 1 day, typically during 1 run“Between-run” or “interassay” CV is determined by comparing results obtained with same assay on different days using same sampleTypically, within-run CV is smaller than between-run CV",
                      "Should be determined at low-range, mid-range, and high-range values",
                      "“Within-run” or “intra-assay” CV is determined by repeating test using same sample on 1 day, typically during 1 run",
                      "“Between-run” or “interassay” CV is determined by comparing results obtained with same assay on different days using same sample",
                      "Typically, within-run CV is smaller than between-run CV"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Positive and Negative Predictive Values": {
            "name": "Positive and Negative Predictive Values",
            "url": "https://app.pathprimer.com/document/c911a112-101c-40c3-99d8-d3a8f420cb3f/lesson/6792c0aa-9fc5-4143-ac04-406d235d317d",
            "content": {
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Negative predictive value (NPV)"
                  },
                  {
                    "text": "Positive predictive value (PPV)"
                  }
                ],
                "Definitions": [
                  {
                    "text": "PPV: Probability that positive test indicates diseaseProportion of persons with positive test who truly have the diseasePPV (%) = 100 x [(true positive)/(true positive + false positive)]Highly dependent on prevalence of disease being testedHigher the prevalence, higher the PPVFor disease with low prevalence, even test with high sensitivity and specificity will yield low predictive value, because most positive test results will be false positives",
                    "sub_points": [
                      "Proportion of persons with positive test who truly have the diseasePPV (%) = 100 x [(true positive)/(true positive + false positive)]",
                      "PPV (%) = 100 x [(true positive)/(true positive + false positive)]",
                      "Highly dependent on prevalence of disease being testedHigher the prevalence, higher the PPVFor disease with low prevalence, even test with high sensitivity and specificity will yield low predictive value, because most positive test results will be false positives",
                      "Higher the prevalence, higher the PPV",
                      "For disease with low prevalence, even test with high sensitivity and specificity will yield low predictive value, because most positive test results will be false positives"
                    ]
                  },
                  {
                    "text": "NPV: Probability that negative test indicates absence of diseaseProportion of persons with negative test who are truly without diseaseNPV (%) = 100 x [(true negative)/(true negative + false negative)]NPV decreases as prevalence of disease increases",
                    "sub_points": [
                      "Proportion of persons with negative test who are truly without diseaseNPV (%) = 100 x [(true negative)/(true negative + false negative)]",
                      "NPV (%) = 100 x [(true negative)/(true negative + false negative)]",
                      "NPV decreases as prevalence of disease increases"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Area Under Receiver Operating Characteristic (ROC) Curve": {
            "name": "Area Under Receiver Operating Characteristic (ROC) Curve",
            "url": "https://app.pathprimer.com/document/8648d9b0-d089-419e-bff5-37b713f87420/lesson/6792c0aa-9fc5-4143-ac04-406d235d317d",
            "content": {
              "KEY CONCEPTS": {
                "Terminology": [
                  {
                    "text": "Receiver operating characteristic (ROC) curve: Graphic representation of the sensitivities and specificities possible when varying the test result cutoff value"
                  },
                  {
                    "text": "Area under ROC curve: Measure of the test’s overall ability to discriminate between disease and nondisease"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Definitions": [
                  {
                    "text": "Receiver operating characteristic (ROC) curveGraphic representation of the sensitivities and specificities possible when varying the test result cutoff valueHelps identify optimal cutoff for diagnostic test to alleviate the trade-off between specificity and sensitivity",
                    "sub_points": [
                      "Graphic representation of the sensitivities and specificities possible when varying the test result cutoff value",
                      "Helps identify optimal cutoff for diagnostic test to alleviate the trade-off between specificity and sensitivity"
                    ]
                  },
                  {
                    "text": "Area under ROC curveMeasure of the test’s overall ability to discriminate between disease and nondiseaseArea of 1 represents a perfect testArea of 0.5 represents a test with no ability to discriminateGenerally, area under ROC curve > 0.8 indicates good discriminatory powerCompare 2 different test methods by comparing the area under the ROC curvesTest method with larger area under the curve has better diagnostic ability",
                    "sub_points": [
                      "Measure of the test’s overall ability to discriminate between disease and nondiseaseArea of 1 represents a perfect testArea of 0.5 represents a test with no ability to discriminate",
                      "Area of 1 represents a perfect test",
                      "Area of 0.5 represents a test with no ability to discriminate",
                      "Generally, area under ROC curve > 0.8 indicates good discriminatory power",
                      "Compare 2 different test methods by comparing the area under the ROC curvesTest method with larger area under the curve has better diagnostic ability",
                      "Test method with larger area under the curve has better diagnostic ability"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Likelihood Ratio": {
            "name": "Likelihood Ratio",
            "url": "https://app.pathprimer.com/document/30090de7-0931-472f-872a-e42180175ab2/lesson/6792c0aa-9fc5-4143-ac04-406d235d317d",
            "content": {
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Likelihood ratio (LR)"
                  }
                ]
              },
              "LABORATORY STATISTICS": {
                "Likelihood Ratio": [
                  {
                    "text": "Convenient measure that combines sensitivity and specificity into a single numberLR of a positive test result is the odds of getting a positive result in a diseased patientCalculated as [sensitivity / (1 ₋ specificity)]LR of a negative test result is the odds of getting a negative result in an unaffected patientCalculated as [(1 ₋ sensitivity) / specificity]",
                    "sub_points": [
                      "LR of a positive test result is the odds of getting a positive result in a diseased patientCalculated as [sensitivity / (1 ₋ specificity)]",
                      "Calculated as [sensitivity / (1 ₋ specificity)]",
                      "LR of a negative test result is the odds of getting a negative result in an unaffected patientCalculated as [(1 ₋ sensitivity) / specificity]",
                      "Calculated as [(1 ₋ sensitivity) / specificity]"
                    ]
                  },
                  {
                    "text": "Can be used to determine the posttest probability of a test result"
                  }
                ],
                "Application": [
                  {
                    "text": "LR and pretest probability (prevalence) can be used to calculate posttest probability (predictive value)"
                  },
                  {
                    "text": "Pretest odds = [pretest probability / (1 ₋ pretest probability)]"
                  },
                  {
                    "text": "Posttest odds = pretest odds x LR"
                  },
                  {
                    "text": "Posttest probability = [posttest odds / (1 + posttest odds)]"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Gaussian Distribution": {
            "name": "Gaussian Distribution",
            "url": "https://app.pathprimer.com/document/2c4bd431-eeb2-4155-be67-f6b1510f493e/lesson/6792c0aa-9fc5-4143-ac04-406d235d317d",
            "content": {
              "TERMINOLOGY": {
                "Definitions": [
                  {
                    "text": "Gaussian (normal) distribution: Spread of data in which elements are distributed symmetrically around mean, with most values close to centerExplicitly described by mathematical equation; therefore, parametric distributionRandom scatter or random selection of population often results in Gaussian normal distributionThis type of distribution is often criterion for completely valid application of many parametric tests",
                    "sub_points": [
                      "Explicitly described by mathematical equation; therefore, parametric distribution",
                      "Random scatter or random selection of population often results in Gaussian normal distribution",
                      "This type of distribution is often criterion for completely valid application of many parametric tests"
                    ]
                  },
                  {
                    "text": "Mean: Number obtained when you add up all numbers and then divide by number of numbers (a.k.a. \"average\")"
                  },
                  {
                    "text": "Median: \"Middle\" value in list of numbers"
                  },
                  {
                    "text": "Mode: Number that is repeated more often than any other"
                  }
                ]
              },
              "LABORATORY STATISTICS": {
                "Gaussian Distribution Described by Mathematical Formula": [
                  {
                    "text": "σ is standard deviation of ideal Gaussian populationCorresponds to distance from mean to x value at which curve has inflection point",
                    "sub_points": [
                      "Corresponds to distance from mean to x value at which curve has inflection point"
                    ]
                  },
                  {
                    "text": "Idealized Gaussian distributionArea under this curve within ± 1 σ from mean is approximately 68.2% of total areaMeaning that 68.2% of data points from Gaussian distribution should fall within ± 1 σ of mean95.5% of data points will be within ± 2 σ of mean99.7% will be within ± 3 σ of meanMean, median, and mode are identical in a perfect Gaussian distribution",
                    "sub_points": [
                      "Area under this curve within ± 1 σ from mean is approximately 68.2% of total areaMeaning that 68.2% of data points from Gaussian distribution should fall within ± 1 σ of mean",
                      "Meaning that 68.2% of data points from Gaussian distribution should fall within ± 1 σ of mean",
                      "95.5% of data points will be within ± 2 σ of mean",
                      "99.7% will be within ± 3 σ of mean",
                      "Mean, median, and mode are identical in a perfect Gaussian distribution"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Reference Ranges": {
            "name": "Reference Ranges",
            "url": "https://app.pathprimer.com/document/866bf6c3-22ef-4980-adcd-4a21bfe02cf2/lesson/6792c0aa-9fc5-4143-ac04-406d235d317d",
            "content": {
              "KEY CONCEPTS": {
                "Terminology": [
                  {
                    "text": "Reference range: Range of “normal” values with which a laboratory result is compared"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Definitions": [
                  {
                    "text": "Reference rangeConsidered range of “normal” values with which laboratory result is comparedUsually defined as range of values into which 95% of nondiseased (“normal”) individuals fall2.5% of nondiseased individuals have laboratory results below reference range2.5% of nondiseased individuals have laboratory results above reference rangeFor some analytes, reference range is defined as “less than” or “greater than” a certain valueSome reference ranges have been defined by professional organizations without adherence to 95% ruleCan be influenced by various factorsLaboratory method used (can often yield significantly different results from a different method)Population characteristicsAgeGenetic backgroundExposure to environmental factorsContainers into which specimens were collectedMode of transport to laboratoryTime between obtaining specimen and analysisStorage conditions of specimens before analysisDetermination of reference rangesLaboratories are strongly encouraged to perform their own studies to establish reference ranges for all analytes they reportUsually by testing many samples from nondiseased individuals in each “partition” (e.g., sex, age group)If this is impossible, laboratory can verify reference interval that it has previously established for a different method by transferenceBy demonstrating that new method yields identical results to previous methodIf the analyte was not previously tested for in laboratory, the laboratory can verify reference interval of another laboratory or manufacturer",
                    "sub_points": [
                      "Considered range of “normal” values with which laboratory result is comparedUsually defined as range of values into which 95% of nondiseased (“normal”) individuals fall2.5% of nondiseased individuals have laboratory results below reference range2.5% of nondiseased individuals have laboratory results above reference rangeFor some analytes, reference range is defined as “less than” or “greater than” a certain valueSome reference ranges have been defined by professional organizations without adherence to 95% rule",
                      "Usually defined as range of values into which 95% of nondiseased (“normal”) individuals fall2.5% of nondiseased individuals have laboratory results below reference range2.5% of nondiseased individuals have laboratory results above reference range",
                      "2.5% of nondiseased individuals have laboratory results below reference range",
                      "2.5% of nondiseased individuals have laboratory results above reference range",
                      "For some analytes, reference range is defined as “less than” or “greater than” a certain value",
                      "Some reference ranges have been defined by professional organizations without adherence to 95% rule",
                      "Can be influenced by various factorsLaboratory method used (can often yield significantly different results from a different method)Population characteristicsAgeGenetic backgroundExposure to environmental factorsContainers into which specimens were collectedMode of transport to laboratoryTime between obtaining specimen and analysisStorage conditions of specimens before analysis",
                      "Laboratory method used (can often yield significantly different results from a different method)",
                      "Population characteristicsAgeGenetic backgroundExposure to environmental factors",
                      "Age",
                      "Genetic background",
                      "Exposure to environmental factors",
                      "Containers into which specimens were collected",
                      "Mode of transport to laboratory",
                      "Time between obtaining specimen and analysis",
                      "Storage conditions of specimens before analysis",
                      "Determination of reference rangesLaboratories are strongly encouraged to perform their own studies to establish reference ranges for all analytes they reportUsually by testing many samples from nondiseased individuals in each “partition” (e.g., sex, age group)If this is impossible, laboratory can verify reference interval that it has previously established for a different method by transferenceBy demonstrating that new method yields identical results to previous methodIf the analyte was not previously tested for in laboratory, the laboratory can verify reference interval of another laboratory or manufacturer",
                      "Laboratories are strongly encouraged to perform their own studies to establish reference ranges for all analytes they reportUsually by testing many samples from nondiseased individuals in each “partition” (e.g., sex, age group)",
                      "Usually by testing many samples from nondiseased individuals in each “partition” (e.g., sex, age group)",
                      "If this is impossible, laboratory can verify reference interval that it has previously established for a different method by transferenceBy demonstrating that new method yields identical results to previous method",
                      "By demonstrating that new method yields identical results to previous method",
                      "If the analyte was not previously tested for in laboratory, the laboratory can verify reference interval of another laboratory or manufacturer"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          }
        }
      },
      "Laboratory Quality Management and Quality Control": {
        "name": "Laboratory Quality Management and Quality Control",
        "url": "https://app.pathprimer.com/lesson/fb06b202-418e-492b-80b2-fe0a3031f2ff",
        "topics": {
          "Analytical Sensitivity and Specificity": {
            "name": "Analytical Sensitivity and Specificity",
            "url": "https://app.pathprimer.com/document/e414ae13-2688-48be-a7c2-930451c2f3e7/lesson/fb06b202-418e-492b-80b2-fe0a3031f2ff",
            "content": {
              "TERMINOLOGY": {
                "Definitions": [
                  {
                    "text": "Analytical sensitivityLowest possible value of analyte accurately and reproducibly measured by assay",
                    "sub_points": [
                      "Lowest possible value of analyte accurately and reproducibly measured by assay"
                    ]
                  },
                  {
                    "text": "Analytical specificityPerformance characteristic of assay that quantifies laboratory test’s ability to measure particular analyte in presence of possible interfering substancesPossible interfering substances vary by analyte and analytical method but can includeHemolysisLipemiaIcterusHyperproteinemiaPrescription drug interferencesGenerally impossible to test forallpossible interferencesMost commonly encountered interfering substances should be determined and assayed",
                    "sub_points": [
                      "Performance characteristic of assay that quantifies laboratory test’s ability to measure particular analyte in presence of possible interfering substancesPossible interfering substances vary by analyte and analytical method but can includeHemolysisLipemiaIcterusHyperproteinemiaPrescription drug interferencesGenerally impossible to test forallpossible interferencesMost commonly encountered interfering substances should be determined and assayed",
                      "Possible interfering substances vary by analyte and analytical method but can includeHemolysisLipemiaIcterusHyperproteinemiaPrescription drug interferences",
                      "Hemolysis",
                      "Lipemia",
                      "Icterus",
                      "Hyperproteinemia",
                      "Prescription drug interferences",
                      "Generally impossible to test forallpossible interferencesMost commonly encountered interfering substances should be determined and assayed",
                      "Most commonly encountered interfering substances should be determined and assayed"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Calibration Verification": {
            "name": "Calibration Verification",
            "url": "https://app.pathprimer.com/document/daa04179-1022-47c7-a20c-38c3502ed759/lesson/fb06b202-418e-492b-80b2-fe0a3031f2ff",
            "content": {
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Clinical Laboratory Improvement Amendments (CLIA)"
                  }
                ]
              },
              "QUALITY": {
                "Quality Control": [
                  {
                    "text": "Calibration verification is quality assurance measureGoal: Ensure that assay maintains accuracy across its analytical rangeShould be performed on medium- and high-complexity assays every 6 months, unless test system meets specific CLIA requirementsMay be more frequent if specified in test system's instructionsShould also be performedAfter major servicing of equipmentAfter changing to new lot of reagentsWhen performance of assay is questionable",
                    "sub_points": [
                      "Goal: Ensure that assay maintains accuracy across its analytical range",
                      "Should be performed on medium- and high-complexity assays every 6 months, unless test system meets specific CLIA requirementsMay be more frequent if specified in test system's instructions",
                      "May be more frequent if specified in test system's instructions",
                      "Should also be performedAfter major servicing of equipmentAfter changing to new lot of reagentsWhen performance of assay is questionable",
                      "After major servicing of equipment",
                      "After changing to new lot of reagents",
                      "When performance of assay is questionable"
                    ]
                  },
                  {
                    "text": "Calibration of assayProcess of adjusting instrument response to maximize correlation with analyte concentrationDistinct from calibration verificationLaboratory should establish, a priori, what tolerance limits it will allow for variation within calibration verificationLimits should be based on clinical accuracy requirement of assayEvery calibration must be documented",
                    "sub_points": [
                      "Process of adjusting instrument response to maximize correlation with analyte concentrationDistinct from calibration verification",
                      "Distinct from calibration verification",
                      "Laboratory should establish, a priori, what tolerance limits it will allow for variation within calibration verificationLimits should be based on clinical accuracy requirement of assay",
                      "Limits should be based on clinical accuracy requirement of assay",
                      "Every calibration must be documented"
                    ]
                  },
                  {
                    "text": "Additional quality assurance measureCompare slope and intercept of current calibration line with previous linesIdentifies calibration shifts in real timeDistinct from calibration verification",
                    "sub_points": [
                      "Compare slope and intercept of current calibration line with previous linesIdentifies calibration shifts in real timeDistinct from calibration verification",
                      "Identifies calibration shifts in real time",
                      "Distinct from calibration verification"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Change Reagent Lot Matrix Effect": {
            "name": "Change Reagent Lot Matrix Effect",
            "url": "https://app.pathprimer.com/document/6de8243b-1431-4443-927f-c8db4eb79fbe/lesson/fb06b202-418e-492b-80b2-fe0a3031f2ff",
            "content": {
              "KEY CONCEPTS": {
                "Quality": [
                  {
                    "text": "Good laboratory practice to run set of samples before and after reagent lot change to ensure that reagent change does not cause shift in analyte quantification"
                  },
                  {
                    "text": "Samples should be both QC material and real patient samples (in matrix) that span analytical range of assay to prove that new reagent lot reacts same as old lot in matrix and in “pseudo-matrix” in which many QC materials are prepared"
                  }
                ]
              },
              "QUALITY": {
                "Quality Control": [
                  {
                    "text": "Good laboratory practice to run set of samples before and after reagent lot change to ensure that reagent change does not cause shift in analyte quantification"
                  },
                  {
                    "text": "Samples should be both quality control (QC) material and real patient samples (in matrix) that span analytical range of assayProves that new reagent lot reacts same as old lot in matrix and in “pseudo-matrix,” in which many QC materials are prepared",
                    "sub_points": [
                      "Proves that new reagent lot reacts same as old lot in matrix and in “pseudo-matrix,” in which many QC materials are prepared"
                    ]
                  },
                  {
                    "text": "Differences in QC values using 2 different lots of reagent may be due to different reactions between new lot and pseudo-matrix of QC materialDifference in reaction may extend to patient samplesShould be excluded by running patient samples across analytical range using both lots",
                    "sub_points": [
                      "Difference in reaction may extend to patient samples",
                      "Should be excluded by running patient samples across analytical range using both lots"
                    ]
                  },
                  {
                    "text": "New reagent lots should be “verified” in the above manner well before old lot expires or runs outRequires good inventory control",
                    "sub_points": [
                      "Requires good inventory control"
                    ]
                  },
                  {
                    "text": "Ultimately, responsibility of laboratory director to ensure good QC practices are followed in laboratory"
                  },
                  {
                    "text": "A priori, the laboratory should establish allowable differences in patient sample values between lotsThese tolerance limits should be established based on clinical accuracy needs of assay",
                    "sub_points": [
                      "These tolerance limits should be established based on clinical accuracy needs of assay"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Delta Checks": {
            "name": "Delta Checks",
            "url": "https://app.pathprimer.com/document/0319bda0-6a5f-435a-bae3-07a0cd80da9c/lesson/fb06b202-418e-492b-80b2-fe0a3031f2ff",
            "content": {
              "QUALITY": {
                "Quality Control": [
                  {
                    "text": "Delta checksCompare current result values with previous result values and flag samples that have exceeded predefined acceptable limits for variationIntended to detect either preanalytic or analytic errors in testing (e.g., specimen mix-up errors, diluted samples, analyzer malfunction)",
                    "sub_points": [
                      "Compare current result values with previous result values and flag samples that have exceeded predefined acceptable limits for variation",
                      "Intended to detect either preanalytic or analytic errors in testing (e.g., specimen mix-up errors, diluted samples, analyzer malfunction)"
                    ]
                  },
                  {
                    "text": "Laboratories individually determine which assays will have delta checks and the acceptable thresholds for intraindividual variationAn assay that commonly has a delta check is the mean corpuscular red blood cell volume",
                    "sub_points": [
                      "An assay that commonly has a delta check is the mean corpuscular red blood cell volume"
                    ]
                  },
                  {
                    "text": "Delta checks are an example of a patient-derived QC procedure"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Lower Limit of Quantification": {
            "name": "Lower Limit of Quantification",
            "url": "https://app.pathprimer.com/document/df67fb59-a43b-46c4-ae32-82c38ee869fc/lesson/fb06b202-418e-492b-80b2-fe0a3031f2ff",
            "content": {
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Coefficient of variation (CV)"
                  },
                  {
                    "text": "Limit of quantification (LoQ)"
                  },
                  {
                    "text": "Standard deviation (SD)"
                  },
                  {
                    "text": "US Food and Drug Administration (FDA)"
                  },
                  {
                    "text": "Limit of detection (LoD)"
                  }
                ]
              },
              "QUALITY": {
                "Lower Limit of Quantification": [
                  {
                    "text": "Definition: Lowest level at which analyte can be reliably quantifiedThis is different from lower limit of detection, which is qualitative assessment of presence of analyte",
                    "sub_points": [
                      "This is different from lower limit of detection, which is qualitative assessment of presence of analyte"
                    ]
                  },
                  {
                    "text": "To validate proposed LoQ, accuracy and reproducibility at this concentration should fall within prespecified limits"
                  },
                  {
                    "text": "By FDA method validation guidelinesCV at LoQ should be < 15%Accuracy at LoQ should be > 80%",
                    "sub_points": [
                      "CV at LoQ should be < 15%",
                      "Accuracy at LoQ should be > 80%"
                    ]
                  },
                  {
                    "text": "Appropriate LoQ is value below lowest clinically relevant value of analyte"
                  },
                  {
                    "text": "If no proposed LoQ is provided in literature or from experience, LoQ of assay can be determined in either of 2 waysEstablish analyte value for which signal/noise ratio is > 10Run matrix blank 20 times and add 5 SDs to average value obtained in this experiment",
                    "sub_points": [
                      "Establish analyte value for which signal/noise ratio is > 10",
                      "Run matrix blank 20 times and add 5 SDs to average value obtained in this experiment"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Method Validation: Coefficient of Determination": {
            "name": "Method Validation: Coefficient of Determination",
            "url": "https://app.pathprimer.com/document/3777e7fa-2b53-437a-adb8-4727eed2730c/lesson/fb06b202-418e-492b-80b2-fe0a3031f2ff",
            "content": {
              "LABORATORY STATISTICS": {
                "Method Validation": [
                  {
                    "text": "Method correlation or comparison study between your laboratory’s proposed method and gold standard or reference method should always be part of method validation for high-complexity, laboratory-developed testSubject to availability of reference method",
                    "sub_points": [
                      "Subject to availability of reference method"
                    ]
                  },
                  {
                    "text": "Classically, reference method is plotted on x-axis and your laboratory’s method on ﻿y﻿-axis"
                  },
                  {
                    "text": "If plot is classically drawn, slope greater than 1 implies positive and proportional bias of your method relative to reference method"
                  },
                  {
                    "text": "If plotted classically,y-intercept term greater than 0 implies constant positive bias"
                  },
                  {
                    "text": "Both constant and proportional biases may coexist in method comparison study"
                  },
                  {
                    "text": "﻿R² ﻿value approaching 1 indicates that linear regression line drawn between 2 methods is excellent fitHowever, high coefficient of determination does not rule out bias in your method",
                    "sub_points": [
                      "However, high coefficient of determination does not rule out bias in your method"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Analytical Errors": {
            "name": "Analytical Errors",
            "url": "https://app.pathprimer.com/document/765abc9f-969b-447d-b570-abbcd2bfed76/lesson/fb06b202-418e-492b-80b2-fe0a3031f2ff",
            "content": {
              "KEY CONCEPTS": {
                "Safety": [
                  {
                    "text": "Errors can occur in any and all phases of total testing process"
                  }
                ]
              },
              "SAFETY": {
                "Errors": [
                  {
                    "text": "Can occur in any and all phases of total testing process"
                  },
                  {
                    "text": "Specimen acquisition, transport, and processing are part of preanalytical phase of testingExamplesMisinterpreted physician test ordersPatient misidentificationIncorrect patient preparation for sampled collectionIncorrect sampling techniqueImproper collection containerImproper method of sample transport or handling",
                    "sub_points": [
                      "ExamplesMisinterpreted physician test ordersPatient misidentificationIncorrect patient preparation for sampled collectionIncorrect sampling techniqueImproper collection containerImproper method of sample transport or handling",
                      "Misinterpreted physician test orders",
                      "Patient misidentification",
                      "Incorrect patient preparation for sampled collection",
                      "Incorrect sampling technique",
                      "Improper collection container",
                      "Improper method of sample transport or handling"
                    ]
                  },
                  {
                    "text": "Analytical phase of testingSample manipulationReagent preparationCalibrationMeasurementInstrument readout",
                    "sub_points": [
                      "Sample manipulation",
                      "Reagent preparation",
                      "Calibration",
                      "Measurement",
                      "Instrument readout"
                    ]
                  },
                  {
                    "text": "Postanalytical phase involves recording test results, interpretation of results, and transmission of reportsExamplesIncorrect result entryFailure to notify physician of critical resultsReports placed in wrong patient chartMiscommunication of results telephoned to nursing units or physiciansManual result entering and reporting increase risk of postanalytical errors",
                    "sub_points": [
                      "ExamplesIncorrect result entryFailure to notify physician of critical resultsReports placed in wrong patient chartMiscommunication of results telephoned to nursing units or physicians",
                      "Incorrect result entry",
                      "Failure to notify physician of critical results",
                      "Reports placed in wrong patient chart",
                      "Miscommunication of results telephoned to nursing units or physicians",
                      "Manual result entering and reporting increase risk of postanalytical errors"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Root Cause Analysis Characteristics": {
            "name": "Root Cause Analysis Characteristics",
            "url": "https://app.pathprimer.com/document/cac20a67-75ef-46f3-85b4-c7336d294bc5/lesson/fb06b202-418e-492b-80b2-fe0a3031f2ff",
            "content": {
              "KEY CONCEPTS": {
                "Quality": [
                  {
                    "text": "RCA is specific type of focused review used for all adverse events or close calls requiring analysis"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Root cause analysis (RCA)"
                  }
                ]
              },
              "QUALITY": {
                "Quality Control": [
                  {
                    "text": "RCA is specific type of focused review used for all adverse events or close calls requiring analysis"
                  },
                  {
                    "text": "RCA characteristicsReview is interdisciplinary, with involvement of those knowledgeable about processes involved in event, and may include staff with varying levels of experience and educational backgroundAnalysis focuses primarily on systems and processes rather than individual performanceAnalysis digs deeper by asking “what” and “why” until all aspects of process are reviewed and contributing factors are consideredAnalysis identifies changes that could be made in systems and processes through redesign or development of new processes and systems that would improve performance and reduce risk of adverse event or close call recurrence",
                    "sub_points": [
                      "Review is interdisciplinary, with involvement of those knowledgeable about processes involved in event, and may include staff with varying levels of experience and educational background",
                      "Analysis focuses primarily on systems and processes rather than individual performance",
                      "Analysis digs deeper by asking “what” and “why” until all aspects of process are reviewed and contributing factors are considered",
                      "Analysis identifies changes that could be made in systems and processes through redesign or development of new processes and systems that would improve performance and reduce risk of adverse event or close call recurrence"
                    ]
                  },
                  {
                    "text": "To help adhere to these characteristics, 5 guidelines must be considered when developing root cause statementsRoot cause statements must include cause and effectNegative descriptions will not be used in root cause statementsEach human error has preceding causeViolations of procedure are not root causes but must have preceding causeFailure to act is only root cause when there is preexisting duty to act",
                    "sub_points": [
                      "Root cause statements must include cause and effect",
                      "Negative descriptions will not be used in root cause statements",
                      "Each human error has preceding cause",
                      "Violations of procedure are not root causes but must have preceding cause",
                      "Failure to act is only root cause when there is preexisting duty to act"
                    ]
                  },
                  {
                    "text": "What RCA must include to be thoroughDetermination of human and other factors most directly associated with event or close call and processes and systems related to its occurrence; there is rarely only 1 underlying causeAnalysis of underlying systems through series of “why” questions to determine where redesigns might reduce riskIdentification of system vulnerabilities or risks and their potential contributions to adverse event or close callDetermination of potential improvement in processes or systems that would tend to decrease likelihood of such events in future, or determination, after analysis, that no such improvement opportunities exist",
                    "sub_points": [
                      "Determination of human and other factors most directly associated with event or close call and processes and systems related to its occurrence; there is rarely only 1 underlying cause",
                      "Analysis of underlying systems through series of “why” questions to determine where redesigns might reduce risk",
                      "Identification of system vulnerabilities or risks and their potential contributions to adverse event or close call",
                      "Determination of potential improvement in processes or systems that would tend to decrease likelihood of such events in future, or determination, after analysis, that no such improvement opportunities exist"
                    ]
                  },
                  {
                    "text": "What RCA must include to be credibleInclude participation by leadership of organization and by individuals knowledgeable about processes and systems under review﻿Can range from chartering RCA team, to direct participation on RCA team, to participation in determination of corrective action planExclude individuals directly involved in adverse event or close call under reviewIn interest of objectivity, these individuals must not be part of RCA teamHowever, their experience and knowledge of situation is vital to RCA process, so they need to be interviewed as part of RCA process and asked for suggestions about how to prevent same or similar situations from happening againBe internally consistent (i.e., not contradict itself or leave obvious questions unanswered)Include consideration of relevant literatureIdentify at least 1 root cause with corresponding action and outcome measureInclude signed concurrence by facility director",
                    "sub_points": [
                      "Include participation by leadership of organization and by individuals knowledgeable about processes and systems under review﻿Can range from chartering RCA team, to direct participation on RCA team, to participation in determination of corrective action plan",
                      "Can range from chartering RCA team, to direct participation on RCA team, to participation in determination of corrective action plan",
                      "Exclude individuals directly involved in adverse event or close call under reviewIn interest of objectivity, these individuals must not be part of RCA teamHowever, their experience and knowledge of situation is vital to RCA process, so they need to be interviewed as part of RCA process and asked for suggestions about how to prevent same or similar situations from happening again",
                      "In interest of objectivity, these individuals must not be part of RCA team",
                      "However, their experience and knowledge of situation is vital to RCA process, so they need to be interviewed as part of RCA process and asked for suggestions about how to prevent same or similar situations from happening again",
                      "Be internally consistent (i.e., not contradict itself or leave obvious questions unanswered)",
                      "Include consideration of relevant literature",
                      "Identify at least 1 root cause with corresponding action and outcome measure",
                      "Include signed concurrence by facility director"
                    ]
                  },
                  {
                    "text": "RCAs should be conducted in blame-free manner"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Six Sigma and Lean Process": {
            "name": "Six Sigma and Lean Process",
            "url": "https://app.pathprimer.com/document/1ac23522-6509-4533-b1d6-662556469d72/lesson/fb06b202-418e-492b-80b2-fe0a3031f2ff",
            "content": {
              "TERMINOLOGY": {
                "Definitions": [
                  {
                    "text": "Six SigmaMethod of quality management that was developed in manufacturingSix Sigma (i.e., 6 SDs or 3.4/1 million) refers to goal of minimizing number of defectsSeeks to minimize number of defects by eliminating causes of defectsRequires full commitment of upper management and all employees involved in manufacturing processCharacterized by champions called “Black Belts” and “Green Belts,” who lead initiatives to identify errors and develop executable solutionsHas been applied to health care for cost savings and quality improvementSome experts think that Six Sigma may not be as effective as it has been in manufacturing",
                    "sub_points": [
                      "Method of quality management that was developed in manufacturing",
                      "Six Sigma (i.e., 6 SDs or 3.4/1 million) refers to goal of minimizing number of defects",
                      "Seeks to minimize number of defects by eliminating causes of defects",
                      "Requires full commitment of upper management and all employees involved in manufacturing process",
                      "Characterized by champions called “Black Belts” and “Green Belts,” who lead initiatives to identify errors and develop executable solutions",
                      "Has been applied to health care for cost savings and quality improvementSome experts think that Six Sigma may not be as effective as it has been in manufacturing",
                      "Some experts think that Six Sigma may not be as effective as it has been in manufacturing"
                    ]
                  },
                  {
                    "text": "Lean processUltimately designed to reduce waste (“nonvalued activities”) and first implemented in Japan by ToyotaIntent is to reduce costs by identifying daily work activities that do not directly add to delivery of laboratory services in most efficient or cost-effective waysLean laboratoriesUse fewer resourcesReduce costsEnhance productivityPromote staff moraleImprove quality of patient care",
                    "sub_points": [
                      "Ultimately designed to reduce waste (“nonvalued activities”) and first implemented in Japan by Toyota",
                      "Intent is to reduce costs by identifying daily work activities that do not directly add to delivery of laboratory services in most efficient or cost-effective ways",
                      "Lean laboratoriesUse fewer resourcesReduce costsEnhance productivityPromote staff moraleImprove quality of patient care",
                      "Use fewer resources",
                      "Reduce costs",
                      "Enhance productivity",
                      "Promote staff morale",
                      "Improve quality of patient care"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Westgard Rules": {
            "name": "Westgard Rules",
            "url": "https://app.pathprimer.com/document/190063cf-1854-470f-b7dc-022772c57386/lesson/fb06b202-418e-492b-80b2-fe0a3031f2ff",
            "content": {
              "KEY CONCEPTS": {
                "Quality": [
                  {
                    "text": "Acceptable range and rules for interpretation of QC results are based on probability of detecting significant analytic error condition with acceptably small false-alert rate"
                  },
                  {
                    "text": "Conventional way to express QC interpretive rules is by using abbreviation nomenclature popularized among clinical laboratories by Westgard"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Quality control (QC)"
                  },
                  {
                    "text": "Standard deviation (SD)"
                  }
                ]
              },
              "QUALITY": {
                "Quality Control": [
                  {
                    "text": "Levey-Jennings control chart plots QC results around their expected mean valueAcceptable limits for deviation of QC results from expected value are determined by laboratoryOften achieved through use of Westgard rules, which are QC interpretive rules for statistical monitoring of assay accuracy and precision",
                    "sub_points": [
                      "Acceptable limits for deviation of QC results from expected value are determined by laboratory",
                      "Often achieved through use of Westgard rules, which are QC interpretive rules for statistical monitoring of assay accuracy and precision"
                    ]
                  }
                ],
                "Establishing Rules to Evaluate QC Results": [
                  {
                    "text": "Acceptable range and rules for interpretation of QC results are based on probability of detecting significant analytic error condition with acceptably small false alert rate"
                  },
                  {
                    "text": "Desired process control performance characteristics must be established for each analyte before appropriate QC rules can be selected"
                  },
                  {
                    "text": "Westgard developed power functions in 1979 to express probability that particular QC interpretive rule would detect systemic error biases at variety of magnitudes"
                  },
                  {
                    "text": "Conventional way to express QC interpretive rules is by using abbreviation nomenclature popularized among clinical laboratories by Westgard1₂s rule (i.e., one value > 2 SDs above or below mean), although very sensitive for detecting systematic error biases, even small ones, also has fairly high false-alert rateTo improve efficiency of QC interpretative rules, combination of rules applied simultaneously may be considered (i.e., multirules)Combination such as 1₂s/2₂s rule would trigger investigation if either rule is brokenThis combines sensitivity and specificity of each individual rule",
                    "sub_points": [
                      "1₂s rule (i.e., one value > 2 SDs above or below mean), although very sensitive for detecting systematic error biases, even small ones, also has fairly high false-alert rate",
                      "To improve efficiency of QC interpretative rules, combination of rules applied simultaneously may be considered (i.e., multirules)Combination such as 1₂s/2₂s rule would trigger investigation if either rule is brokenThis combines sensitivity and specificity of each individual rule",
                      "Combination such as 1₂s/2₂s rule would trigger investigation if either rule is brokenThis combines sensitivity and specificity of each individual rule",
                      "This combines sensitivity and specificity of each individual rule"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Antibody Carryover": {
            "name": "Antibody Carryover",
            "url": "https://app.pathprimer.com/document/69252459-6548-4ad7-a30e-6444a1682b99/lesson/fb06b202-418e-492b-80b2-fe0a3031f2ff",
            "content": {
              "QUALITY": {
                "Quality Control": [
                  {
                    "text": "CarryoverTransfer of quantity of analyte from one reaction into next subsequent reactionCould potentially cause false elevation in patient results and, therefore, should be assessed when validating new test system, if applicable to methodology",
                    "sub_points": [
                      "Transfer of quantity of analyte from one reaction into next subsequent reactionCould potentially cause false elevation in patient results and, therefore, should be assessed when validating new test system, if applicable to methodology",
                      "Could potentially cause false elevation in patient results and, therefore, should be assessed when validating new test system, if applicable to methodology"
                    ]
                  },
                  {
                    "text": "AccuracyAssessed by measuring analyte in reference material with known concentration and comparing result with certified value",
                    "sub_points": [
                      "Assessed by measuring analyte in reference material with known concentration and comparing result with certified value"
                    ]
                  },
                  {
                    "text": "PrecisionAgreement between result values obtained by repeat measurements of quantity",
                    "sub_points": [
                      "Agreement between result values obtained by repeat measurements of quantity"
                    ]
                  },
                  {
                    "text": "Limit of detectionLowest concentration that can be reliably detected of analyte in sample",
                    "sub_points": [
                      "Lowest concentration that can be reliably detected of analyte in sample"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          }
        }
      },
      "Laboratory Management Regulations": {
        "name": "Laboratory Management Regulations",
        "url": "https://app.pathprimer.com/lesson/4ab197e7-eaee-44a2-91a6-2e427e199ae5",
        "topics": {
          "1990 Act": {
            "name": "1990 Act",
            "url": "https://app.pathprimer.com/document/0992a0b5-83ee-4ec2-8af1-b51dd7d3bc8b/lesson/4ab197e7-eaee-44a2-91a6-2e427e199ae5",
            "content": {
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Diagnosis-related group (DRG)"
                  },
                  {
                    "text": "US Department of Health and Human Services (HHS)"
                  },
                  {
                    "text": "Inpatient prospective payment system (IPPS)"
                  }
                ]
              },
              "LABORATORY REGULATION": {
                "Three-Day Rule of 1990": [
                  {
                    "text": "States that hospitals must include in charges for inpatient hospital stay charges for all laboratory services performed in 3-day period prior to hospital admissionApplies to hospitals subject to IPPSFor hospitals not subject to IPPS (e.g., psychiatric hospitals and units, inpatient rehabilitation hospitals and units, long-term care hospitals, children's hospitals, and cancer hospitals), statutory payment window is 1 day preceding date of patient's admission",
                    "sub_points": [
                      "Applies to hospitals subject to IPPS",
                      "For hospitals not subject to IPPS (e.g., psychiatric hospitals and units, inpatient rehabilitation hospitals and units, long-term care hospitals, children's hospitals, and cancer hospitals), statutory payment window is 1 day preceding date of patient's admission"
                    ]
                  },
                  {
                    "text": "Directs HHS to develop outpatient DRG system"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Agency for Healthcare Research and Quality (AHRQ)": {
            "name": "Agency for Healthcare Research and Quality (AHRQ)",
            "url": "https://app.pathprimer.com/document/0170756b-5f68-4e25-a3bc-2cebdeffa851/lesson/4ab197e7-eaee-44a2-91a6-2e427e199ae5",
            "content": {
              "OVERVIEW": {
                "Organization and Goals": [
                  {
                    "text": "AHRQ: Agency of DHHS"
                  },
                  {
                    "text": "GoalsTo improve patient care through its initiativesQualitySafetyEffectivenessEfficiency",
                    "sub_points": [
                      "To improve patient care through its initiativesQualitySafetyEffectivenessEfficiency",
                      "Quality",
                      "Safety",
                      "Effectiveness",
                      "Efficiency"
                    ]
                  },
                  {
                    "text": "Focus areasNew treatment effectiveness comparisonQuality improvementPatient safetyHealth information technology use in patient safetyCost effectiveness of healthcareImproving access to healthcareProviding data for clinicians and policymakers",
                    "sub_points": [
                      "New treatment effectiveness comparison",
                      "Quality improvement",
                      "Patient safety",
                      "Health information technology use in patient safety",
                      "Cost effectiveness of healthcare",
                      "Improving access to healthcare",
                      "Providing data for clinicians and policymakers"
                    ]
                  },
                  {
                    "text": "Applies > 80% of its budget for research; however, NIH is largest source of funding for biomedical research in United States"
                  },
                  {
                    "text": "Publishes technology assessments to provide information to other agenciese.g., AHRQ provided summary to FDA on scientific evidence on quality of LDTs (i.e., “home-brew” tests)",
                    "sub_points": [
                      "e.g., AHRQ provided summary to FDA on scientific evidence on quality of LDTs (i.e., “home-brew” tests)"
                    ]
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Agency for Healthcare Research and Quality (AHRQ)"
                  },
                  {
                    "text": "Department of Health and Human Services (DHHS)"
                  },
                  {
                    "text": "Food and Drug Administration (FDA)"
                  },
                  {
                    "text": "Laboratory-developed test (LDT)"
                  },
                  {
                    "text": "National Institutes of Health (NIH)"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Biosafety Levels": {
            "name": "Biosafety Levels",
            "url": "https://app.pathprimer.com/document/0b06d127-fe30-47c4-b084-0a69e3413897/lesson/4ab197e7-eaee-44a2-91a6-2e427e199ae5",
            "content": {
              "OVERVIEW": {
                "Biosafety Level 1": [
                  {
                    "text": "Suitable for work involvingWell-characterized agents not known to consistently cause disease in healthy adult humansMinimal potential hazard to laboratory personnel and the environmentExamples: High school science classrooms; acceptable nonpathogenic organisms, such asEscherichia coli",
                    "sub_points": [
                      "Well-characterized agents not known to consistently cause disease in healthy adult humans",
                      "Minimal potential hazard to laboratory personnel and the environment",
                      "Examples: High school science classrooms; acceptable nonpathogenic organisms, such asEscherichia coli"
                    ]
                  }
                ],
                "Biosafety Level 2": [
                  {
                    "text": "Suitable for work involvingAgents of moderate potential hazard to personnel and the environmentExamples: Use of biosafety cabinets required for potential infectious aerosolization; organisms such asStaphylococcus aureus",
                    "sub_points": [
                      "Agents of moderate potential hazard to personnel and the environment",
                      "Examples: Use of biosafety cabinets required for potential infectious aerosolization; organisms such asStaphylococcus aureus"
                    ]
                  }
                ],
                "Biosafety Level 3": [
                  {
                    "text": "Suitable for work involvingIndigenous or exotic agents that may cause serious or potentially lethal disease after inhalationMust be separated from areas with unrestricted traffic flow by at least 2 sets of self-closing doors (to prevent aerosol escape)Windows must be sealed; ventilation must force air from clean areas to where infectious agents handledExamples:Francisella tularensis﻿,﻿Mycobacterium tuberculosis, severe acute respiratory syndrome (SARS)",
                    "sub_points": [
                      "Indigenous or exotic agents that may cause serious or potentially lethal disease after inhalation",
                      "Must be separated from areas with unrestricted traffic flow by at least 2 sets of self-closing doors (to prevent aerosol escape)",
                      "Windows must be sealed; ventilation must force air from clean areas to where infectious agents handled",
                      "Examples:Francisella tularensis﻿,﻿Mycobacterium tuberculosis, severe acute respiratory syndrome (SARS)"
                    ]
                  }
                ],
                "Biosafety Level 4": [
                  {
                    "text": "Suitable for work involvingRequires cabinet laboratory or positive pressure suitDangerous and exotic agents that pose high individual risk of aerosol-transmitted laboratory infectionsIncludes agents that cause severe to fatal disease in humans for which vaccines or other treatments are not availableExamples: Ebola, smallpox",
                    "sub_points": [
                      "Requires cabinet laboratory or positive pressure suit",
                      "Dangerous and exotic agents that pose high individual risk of aerosol-transmitted laboratory infectionsIncludes agents that cause severe to fatal disease in humans for which vaccines or other treatments are not availableExamples: Ebola, smallpox",
                      "Includes agents that cause severe to fatal disease in humans for which vaccines or other treatments are not available",
                      "Examples: Ebola, smallpox"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "College of American Pathologists (CAP) Laboratory Inspection": {
            "name": "College of American Pathologists (CAP) Laboratory Inspection",
            "url": "https://app.pathprimer.com/document/63d08b46-4b45-469f-bae3-81854605d25b/lesson/4ab197e7-eaee-44a2-91a6-2e427e199ae5",
            "content": {
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Centers for Medicare and Medicaid Services (CMS)"
                  },
                  {
                    "text": "Clinical Laboratory Improvement Amendments (CLIA)"
                  },
                  {
                    "text": "College of American Pathologists (CAP)"
                  }
                ]
              },
              "LABORATORY REGULATION": {
                "CAP Laboratory Accreditation Program": [
                  {
                    "text": "CAP offers laboratory accreditation program that routinely inspects laboratories on 2-year cycle"
                  },
                  {
                    "text": "CLIA-accredited laboratory has been inspected by accrediting organizations approved by CMS"
                  },
                  {
                    "text": "Approved accrediting organization can inspect laboratory in lieu of CMS"
                  },
                  {
                    "text": "CMS has granted CAP Laboratory Accreditation Program deeming authority"
                  },
                  {
                    "text": "CAP inspections are guided by detailed checklists created for different areas of laboratory"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Clinical Laboratory Improvement Amendments (CLIA) Regulations": {
            "name": "Clinical Laboratory Improvement Amendments (CLIA) Regulations",
            "url": "https://app.pathprimer.com/document/b2acf431-750c-4d0c-86bc-aec9e7024958/lesson/4ab197e7-eaee-44a2-91a6-2e427e199ae5",
            "content": {
              "KEY CONCEPTS": {
                "Laboratory Regulation": [
                  {
                    "text": "CLIA program is designed to ensure quality laboratory testing"
                  },
                  {
                    "text": "CMS oversees operation and enforcement of regulations"
                  }
                ]
              },
              "OVERVIEW": {
                "CLIA Program Basics": [
                  {
                    "text": "CLIA was passed by Congress in 1988"
                  },
                  {
                    "text": "CLIA program is designed to ensure quality laboratory testing"
                  },
                  {
                    "text": "CMS oversees operation and enforcement of regulations"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Centers for Medicare and Medicaid Services (CMS)"
                  },
                  {
                    "text": "Clinical Laboratory Improvement Amendments (CLIA)"
                  },
                  {
                    "text": "Accreditation Commission for Health Care, Inc (ACHC)"
                  },
                  {
                    "text": "Coefficient of variation (CV)"
                  },
                  {
                    "text": "College of American Pathologists (CAP)"
                  },
                  {
                    "text": "Quality control (QC)"
                  },
                  {
                    "text": "Standard deviation (SD)"
                  },
                  {
                    "text": "US Food and Drug Administration (FDA)"
                  }
                ]
              },
              "LABORATORY REGULATION": {
                "CLIA Certificate and Certificate of Waiver": [
                  {
                    "text": "3 levels of testing are recognized by CLIAWaivedModerate complexityHigh complexity",
                    "sub_points": [
                      "Waived",
                      "Moderate complexity",
                      "High complexity"
                    ]
                  },
                  {
                    "text": "Certificate of waiver is issued to laboratory that performs ﻿only﻿waived testingWaived tests are simple laboratory examinations and procedures with insignificant risk of erroneous result",
                    "sub_points": [
                      "Waived tests are simple laboratory examinations and procedures with insignificant risk of erroneous result"
                    ]
                  },
                  {
                    "text": "Certificate of registration is issued to laboratory to allow laboratory to conduct nonwaived (i.e., moderate-complexity &/or high-complexity) testing until laboratory is inspected by state health department or accreditation agency to determine its compliance with CLIA regulationsOnly laboratories applying for certificate of compliance or certificate of accreditation will receive certificate of registration",
                    "sub_points": [
                      "Only laboratories applying for certificate of compliance or certificate of accreditation will receive certificate of registration"
                    ]
                  },
                  {
                    "text": "Certificate of compliance is issued to laboratory once state health department conducts inspection and determines that laboratory is compliant with all applicable CLIA requirementsThis type of certificate is issued to laboratory that performs nonwaived (i.e., moderate-complexity &/or high-complexity) testingNot needed to add waived test",
                    "sub_points": [
                      "This type of certificate is issued to laboratory that performs nonwaived (i.e., moderate-complexity &/or high-complexity) testing",
                      "Not needed to add waived test"
                    ]
                  },
                  {
                    "text": "Certificate of accreditation is issued to laboratory on basis of laboratory's accreditation by accreditation organization-approved by CMSThis type of certificate is issued to laboratory that performs nonwaived (i.e., moderate-complexity &/or high-complexity) testing",
                    "sub_points": [
                      "This type of certificate is issued to laboratory that performs nonwaived (i.e., moderate-complexity &/or high-complexity) testing"
                    ]
                  },
                  {
                    "text": "7 CMS-approved accreditation agenciesAABBAmerican Association for Laboratory AccreditationAccreditation Commission for Health Care, IncAmerican Society for Histocompatibility and ImmunogeneticsCOLACollege of American PathologistsThe Joint Commission",
                    "sub_points": [
                      "AABB",
                      "American Association for Laboratory Accreditation",
                      "Accreditation Commission for Health Care, Inc",
                      "American Society for Histocompatibility and Immunogenetics",
                      "COLA",
                      "College of American Pathologists",
                      "The Joint Commission"
                    ]
                  }
                ],
                "CLIA Personnel Requirements": [
                  {
                    "text": "CLIA requires that laboratory performing high-complexity testing be staffed by personnel who can fulfill qualifications and responsibilities of technical and general supervisor, testing personnel, and clinical consultant"
                  },
                  {
                    "text": "If laboratory performs mix of moderate-complexity and high-complexity testing, only those employees working on high-complexity testing must meet above requirements"
                  },
                  {
                    "text": "These 4 positions can be filled by 1 person (i.e., laboratory director), as long and he or she meets qualifications and is able to meet established responsibilities defined in CLIA"
                  },
                  {
                    "text": "It is laboratory director’s responsibility to ensure that appropriate personnel work in laboratory"
                  },
                  {
                    "text": "Personnel requirements for laboratory are determined by level of complexity of assays run in laboratory"
                  }
                ],
                "Retention of Materials (Both CLIA and CAP)": [
                  {
                    "text": "Laboratories must retain certain materials for at least 2 yearsTest requisitionsProficiency testing recordsTesting standard operating procedures after discontinuationQuality system assessment records (i.e., QC records)",
                    "sub_points": [
                      "Test requisitions",
                      "Proficiency testing records",
                      "Testing standard operating procedures after discontinuation",
                      "Quality system assessment records (i.e., QC records)"
                    ]
                  },
                  {
                    "text": "Histopathology slide preparations must be retained for 10 years after date of examination"
                  },
                  {
                    "text": "Cytopathology slide preparations must be retained for 5 years from date of examination"
                  },
                  {
                    "text": "Flow cytometry plots and histograms must be kept for 10 years"
                  },
                  {
                    "text": "CAP requires all peripheral blood smears/body fluid smears to be retained for 7 days"
                  },
                  {
                    "text": "CAP requires all stained slides for microbiology (i.e., Gram stains) be kept for 7 days"
                  },
                  {
                    "text": "CAP requires blood bank QC records be kept for minimum of 5 years"
                  },
                  {
                    "text": "CAP requires retention of QC records for general laboratory for 2 years"
                  },
                  {
                    "text": "Different durations of material retention based on type of autopsyNonforensic autopsy paraffin blocks/slides/reports must be kept for 10 yearsForensic autopsy paraffin blocks, slides, gross images, accessioning log records, dried bloodstains, and frozen tissue for DNA must be kept indefinitely",
                    "sub_points": [
                      "Nonforensic autopsy paraffin blocks/slides/reports must be kept for 10 years",
                      "Forensic autopsy paraffin blocks, slides, gross images, accessioning log records, dried bloodstains, and frozen tissue for DNA must be kept indefinitely"
                    ]
                  }
                ]
              },
              "QUALITY": {
                "Quality Control": [
                  {
                    "text": "CLIA guidelines require laboratories to confirm manufacturer’s claims on assay performance prior to instituting assay in laboratory"
                  },
                  {
                    "text": "4 performance characteristics of FDA-approved, moderate-complexity assay must, at minimum, be confirmedAccuracyReproducibilityReportable rangeReference range",
                    "sub_points": [
                      "Accuracy",
                      "Reproducibility",
                      "Reportable range",
                      "Reference range"
                    ]
                  },
                  {
                    "text": "Laboratory-developed tests are considered high-complexity tests and are held to different standard of validation by CLIA regulationsAdditional performance parameters must be assessed",
                    "sub_points": [
                      "Additional performance parameters must be assessed"
                    ]
                  },
                  {
                    "text": "Purpose of method validationAssess degree of uncertainty in measurements made by assayPoint out assay weaknesses and potential for error",
                    "sub_points": [
                      "Assess degree of uncertainty in measurements made by assay",
                      "Point out assay weaknesses and potential for error"
                    ]
                  },
                  {
                    "text": "Accuracy is usually validated by running standards of known concentrations and comparing measured concentration as percentage of expected concentration"
                  },
                  {
                    "text": "Precision or reproducibility (inter-run) is generally assessed by running at least 2 levels of analyte in quadruplicate over 5 daysPrecision is expressed as % CV ([mean/SD] x 100%)",
                    "sub_points": [
                      "Precision is expressed as % CV ([mean/SD] x 100%)"
                    ]
                  },
                  {
                    "text": "Reportable range is established by running increasing concentrations of analyte and choosing range of concentrations in which instrument response increases﻿ linearly﻿with analyte concentrationLinear regression procedure is usually used",
                    "sub_points": [
                      "Linear regression procedure is usually used"
                    ]
                  },
                  {
                    "text": "QC samples must be assayed once every 24 hours or more frequently if recommended by manufacturerLaboratories can assay QC samples more frequently if deemed necessary to ensure accurate resultsQC samples should be assayed after calibration or maintenance of analyzer to verify correct method performanceBlood gas measurements have separate, stricter QC requirementsCLIA requires at least 1 QC level to be assayed every 8 hours for blood gas measurementsIn addition to running QC samples every 8 hours for blood gas measurements, CLIA also requires control sample be run with every patient sample, unless analyzer calibrates itself every 30 minutes",
                    "sub_points": [
                      "Laboratories can assay QC samples more frequently if deemed necessary to ensure accurate results",
                      "QC samples should be assayed after calibration or maintenance of analyzer to verify correct method performanceBlood gas measurements have separate, stricter QC requirementsCLIA requires at least 1 QC level to be assayed every 8 hours for blood gas measurementsIn addition to running QC samples every 8 hours for blood gas measurements, CLIA also requires control sample be run with every patient sample, unless analyzer calibrates itself every 30 minutes",
                      "Blood gas measurements have separate, stricter QC requirements",
                      "CLIA requires at least 1 QC level to be assayed every 8 hours for blood gas measurements",
                      "In addition to running QC samples every 8 hours for blood gas measurements, CLIA also requires control sample be run with every patient sample, unless analyzer calibrates itself every 30 minutes"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Family Medical Leave Act (FMLA)": {
            "name": "Family Medical Leave Act (FMLA)",
            "url": "https://app.pathprimer.com/document/c9b8ffae-34b3-439a-83bd-67e0196f488e/lesson/4ab197e7-eaee-44a2-91a6-2e427e199ae5",
            "content": {
              "KEY CONCEPTS": {
                "Laboratory Regulation": [
                  {
                    "text": "FMLA requires employers to offer 12 weeks of unpaid job-protected leave per year for qualifying reasons"
                  },
                  {
                    "text": "Requires health insurance to be maintained during the leave if insurance was provided before the leave was taken"
                  },
                  {
                    "text": "Employees are eligible if they have worked for the employer at least 12 months"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Family Medical Leave Act (FMLA)"
                  }
                ]
              },
              "LABORATORY REGULATION": {
                "Specific Requirements": [
                  {
                    "text": "FMLA requires employers to offer up to 12 weeks of unpaid job-protected leave per year for qualifying reasonsQualifying reasons includeBirth of a childPlacement of a child for adoption or foster careCare of an immediate family member with a serious health conditionEmployee medical leave, if unable to work due to serious health condition",
                    "sub_points": [
                      "Qualifying reasons includeBirth of a childPlacement of a child for adoption or foster careCare of an immediate family member with a serious health conditionEmployee medical leave, if unable to work due to serious health condition",
                      "Birth of a child",
                      "Placement of a child for adoption or foster care",
                      "Care of an immediate family member with a serious health condition",
                      "Employee medical leave, if unable to work due to serious health condition"
                    ]
                  },
                  {
                    "text": "Applies to all public agencies, elementary and secondary schools (public and private), and companies with 50+ employees"
                  },
                  {
                    "text": "Enforced by US Department of Labor’s Employment Standards Administration, Wage and Hour Division"
                  },
                  {
                    "text": "Requires health insurance to be maintained during the leave if insurance was provided before leave was taken"
                  },
                  {
                    "text": "Employees are eligible if they have worked for the employer at least 12 months"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "FDA Regulations": {
            "name": "FDA Regulations",
            "url": "https://app.pathprimer.com/document/0fc07a50-3896-4628-9345-83a2fbf4b839/lesson/4ab197e7-eaee-44a2-91a6-2e427e199ae5",
            "content": {
              "KEY CONCEPTS": {
                "Terminology": [
                  {
                    "text": "LDT: Test designed in a laboratory for specific use ONLY in that laboratory"
                  }
                ],
                "Laboratory Regulation": [
                  {
                    "text": "All blood-banking establishments must be licensed by FDA"
                  },
                  {
                    "text": "FDA considers LDTs medical devicesLaboratories producing LDTs are considered manufacturers of medical devices",
                    "sub_points": [
                      "Laboratories producing LDTs are considered manufacturers of medical devices"
                    ]
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Centers for Medicare and Medicaid Services (CMS)"
                  },
                  {
                    "text": "Clinical Laboratory Improvement Amendments (CLIA)"
                  },
                  {
                    "text": "College of American Pathologists (CAP)"
                  },
                  {
                    "text": "Laboratory-developed test (LDT)"
                  },
                  {
                    "text": "US Federal Drug Administration (FDA)"
                  }
                ],
                "Definitions": [
                  {
                    "text": "LDT: Test designed in a laboratory for specific use ONLY in that laboratory"
                  },
                  {
                    "text": "Medical device: (According to FDA) Any instrument, apparatus, or other article used to prevent, diagnose, mitigate, or treat a disease or to affect the structure or function of the body, with the exception of drugs"
                  }
                ]
              },
              "LABORATORY REGULATION": {
                "Regulation of Blood Banks": [
                  {
                    "text": "All blood-banking establishments must be licensed by FDABlood products are regulated by the federal government as pharmaceuticals",
                    "sub_points": [
                      "Blood products are regulated by the federal government as pharmaceuticals"
                    ]
                  },
                  {
                    "text": "FDAConducts unannounced inspections of all blood banks on a periodic basisPromulgates criteria for blood donor eligibility",
                    "sub_points": [
                      "Conducts unannounced inspections of all blood banks on a periodic basis",
                      "Promulgates criteria for blood donor eligibility"
                    ]
                  },
                  {
                    "text": "CMSOversees CLIA regulatory program",
                    "sub_points": [
                      "Oversees CLIA regulatory program"
                    ]
                  },
                  {
                    "text": "AABB, CAP, and Joint CommissionEstablish accreditation standards for blood banksConduct inspections",
                    "sub_points": [
                      "Establish accreditation standards for blood banks",
                      "Conduct inspections"
                    ]
                  }
                ],
                "Laboratory-Developed Tests": [
                  {
                    "text": "FDA considers LDTs medical devicesLaboratories producing LDTs are considered manufacturers of medical devices",
                    "sub_points": [
                      "Laboratories producing LDTs are considered manufacturers of medical devices"
                    ]
                  },
                  {
                    "text": "FDA exercises enforcement discretion with regard to LDTs to enable implementation of the newest diagnostics in clinical laboratories in a meaningful time period"
                  },
                  {
                    "text": "FDA’s proposed jurisdiction over LDTs is the subject of debateParticularly from CMS, which considers LDTs a service offered by the laboratory to ordering physicians without any reagents or devices crossing state bordersTherefore, they argue that FDA has no authority in regulating LDTs",
                    "sub_points": [
                      "Particularly from CMS, which considers LDTs a service offered by the laboratory to ordering physicians without any reagents or devices crossing state borders",
                      "Therefore, they argue that FDA has no authority in regulating LDTs"
                    ]
                  },
                  {
                    "text": "Although LDTs are not actively regulated by FDA, CLIA has a strict set of performance criteria that must be established in method validation before releasing patient resultsThese include (but are not limited to)LinearityReproducibilityAnalytical sensitivity/specificityReference rangeRecovery/accuracy",
                    "sub_points": [
                      "These include (but are not limited to)LinearityReproducibilityAnalytical sensitivity/specificityReference rangeRecovery/accuracy",
                      "Linearity",
                      "Reproducibility",
                      "Analytical sensitivity/specificity",
                      "Reference range",
                      "Recovery/accuracy"
                    ]
                  },
                  {
                    "text": "LDT validation studies should be tailored to address issues specific to the technology being usede.g., ionization suppression experiments should always be included in methods using electrospray ionization–mass spectrometry, despite this not being specifically listed by CLIA regulations",
                    "sub_points": [
                      "e.g., ionization suppression experiments should always be included in methods using electrospray ionization–mass spectrometry, despite this not being specifically listed by CLIA regulations"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Discrimination": {
            "name": "Discrimination",
            "url": "https://app.pathprimer.com/document/65dba269-61d2-4518-82b5-566940bc14d9/lesson/4ab197e7-eaee-44a2-91a6-2e427e199ae5",
            "content": {
              "KEY CONCEPTS": {
                "Laboratory Regulation": [
                  {
                    "text": "Title VII of the Civil Rights Law of 1964Illegal to discriminate against someone on the basis of race, color, religion, national origin, or gender",
                    "sub_points": [
                      "Illegal to discriminate against someone on the basis of race, color, religion, national origin, or gender"
                    ]
                  },
                  {
                    "text": "Age Discrimination in Employment Act of 1967Protects people aged 40 years or older from discrimination based on age",
                    "sub_points": [
                      "Protects people aged 40 years or older from discrimination based on age"
                    ]
                  },
                  {
                    "text": "Americans with Disabilities Act of 1990Illegal to discriminate against a qualified person who has a disability",
                    "sub_points": [
                      "Illegal to discriminate against a qualified person who has a disability"
                    ]
                  },
                  {
                    "text": "Genetic Information Nondiscrimination Act of 2009Illegal to discriminate against employees or applicants because of genetic information",
                    "sub_points": [
                      "Illegal to discriminate against employees or applicants because of genetic information"
                    ]
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Americans with Disabilities Act (ADA)"
                  }
                ]
              },
              "LABORATORY REGULATION": {
                "Title VII of the Civil Rights Law of 1964": [
                  {
                    "text": "Illegal to discriminate against someone on the basis of race, color, religion, national origin, or gender"
                  },
                  {
                    "text": "Illegal to retaliate against a person because the person complained about discrimination, filed a charge of discrimination, or participated in an employment discrimination investigation or lawsuit"
                  },
                  {
                    "text": "Employers must reasonably accommodate an applicant's or employee's sincerely held religious practices, unless doing so would impose an undue hardship on the operation of the employer’s business"
                  }
                ],
                "Age Discrimination in Employment Act of 1967": [
                  {
                    "text": "Protects people aged 40 years or older from discrimination based on age"
                  },
                  {
                    "text": "Illegal to retaliate against a person because the person complained about discrimination, filed a charge of discrimination, or participated in an employment discrimination investigation or lawsuit"
                  }
                ],
                "Americans with Disabilities Act of 1990": [
                  {
                    "text": "Persons considered disabled under the lawHave a physical or mental condition that substantially limits a major life activity (such as walking, talking, seeing, hearing, learning)Have a history of a disability (such as cancer that is in remission)Are believed to have a physical or mental impairment that is not transitory (lasting or expected to last 6 months or less) and minor (even if he or she does not have such an impairment)",
                    "sub_points": [
                      "Have a physical or mental condition that substantially limits a major life activity (such as walking, talking, seeing, hearing, learning)",
                      "Have a history of a disability (such as cancer that is in remission)",
                      "Are believed to have a physical or mental impairment that is not transitory (lasting or expected to last 6 months or less) and minor (even if he or she does not have such an impairment)"
                    ]
                  },
                  {
                    "text": "Title I of the ADA﻿Illegal to discriminate against a qualified person who has a disability, in the private sector or in state and local governmentsIllegal to retaliate against a person because the person complained about discrimination, filed a charge of discrimination, or participated in an employment discrimination investigation or lawsuitEmployers must reasonably accommodate the known physical or mental limitations of an otherwise qualified individual with a disability who is an applicant or employee, unless doing so would impose an undue hardship on the operation of the employer’s business",
                    "sub_points": [
                      "Illegal to discriminate against a qualified person who has a disability, in the private sector or in state and local governments",
                      "Illegal to retaliate against a person because the person complained about discrimination, filed a charge of discrimination, or participated in an employment discrimination investigation or lawsuit",
                      "Employers must reasonably accommodate the known physical or mental limitations of an otherwise qualified individual with a disability who is an applicant or employee, unless doing so would impose an undue hardship on the operation of the employer’s business"
                    ]
                  }
                ],
                "Genetic Information Nondiscrimination Act of 2009": [
                  {
                    "text": "Illegal to discriminate against employees or applicants because of genetic informationInformation about an individual's genetic testsInformation about genetic tests of an individual's family membersInformation about any disease, disorder, or condition of an individual’s family members (i.e., an individual’s family medical history)",
                    "sub_points": [
                      "Information about an individual's genetic tests",
                      "Information about genetic tests of an individual's family members",
                      "Information about any disease, disorder, or condition of an individual’s family members (i.e., an individual’s family medical history)"
                    ]
                  },
                  {
                    "text": "Illegal to retaliate against a person because the person complained about discrimination, filed a charge of discrimination, or participated in an employment discrimination investigation or lawsuit"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "ISO Standard 15189": {
            "name": "ISO Standard 15189",
            "url": "https://app.pathprimer.com/document/2b68a040-20fa-44f1-9245-c16f57dea0a9/lesson/4ab197e7-eaee-44a2-91a6-2e427e199ae5",
            "content": {
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "International Organization for Standardization (ISO)"
                  }
                ]
              },
              "SAFETY": {
                "International Organization for Standardization": [
                  {
                    "text": "Nongovernmental organization that develops standards for variety of disciplines in business, government, and societyNetwork of national standards institutes of 163 countries",
                    "sub_points": [
                      "Network of national standards institutes of 163 countries"
                    ]
                  },
                  {
                    "text": "International standards for technical regulations on products, production methods, and services help ensure certain level of performance and safety worldwide"
                  },
                  {
                    "text": "Adherence to ISO standards is voluntary in United StatesISO has no legal authority to enforce its standards unless a country has incorporated them into their national laws",
                    "sub_points": [
                      "ISO has no legal authority to enforce its standards unless a country has incorporated them into their national laws"
                    ]
                  },
                  {
                    "text": "ISO 15189:2007 “Medical laboratories—Particular requirements for quality and competence\"Designed specifically for clinical and medical laboratoriesQuality management standardsTechnical competence standardsTest reliability standards",
                    "sub_points": [
                      "Designed specifically for clinical and medical laboratories",
                      "Quality management standards",
                      "Technical competence standards",
                      "Test reliability standards"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Medicaid and Medicare Administration": {
            "name": "Medicaid and Medicare Administration",
            "url": "https://app.pathprimer.com/document/79b99748-cf0f-4df5-99c2-ecb80e7d9e0b/lesson/4ab197e7-eaee-44a2-91a6-2e427e199ae5",
            "content": {
              "LABORATORY REGULATION": {
                "Medicaid Overview": [
                  {
                    "text": "Individual states establish and administer their own Medicaid programs"
                  },
                  {
                    "text": "Medicaid is jointly funded by the federal government and state governments"
                  },
                  {
                    "text": "To participate in Medicaid, states are required to offer health insurance coverage to certain population groups"
                  },
                  {
                    "text": "States can expand health insurance coverage to additional population groups if they deem appropriate"
                  },
                  {
                    "text": "States receive federal matching funds to provide benefits"
                  }
                ],
                "Medicare Overview": [
                  {
                    "text": "Medicare is the largest insurance program in the United States"
                  },
                  {
                    "text": "In many hospitals, it accounts for 25-40% of all revenue"
                  },
                  {
                    "text": "Outpatient services are reimbursed differently from inpatient services"
                  },
                  {
                    "text": "Medicare inpatientsDiagnosis-related groups (DRGs) make up a patient classification system used to reimburse inpatient ('Part A') hospital costs for Medicare patientsAlthough costs associated with inpatient clinical laboratory tests are included in the DRG, it does not cover physician services ('Part B')After Medicare patient has been discharged from the hospital, the patient’s medical record is reviewed by health information management coders and is assigned appropriate ICD-9-CM and Healthcare Common Procedure Coding System (HCPCS) codes for 1 or more diagnoses and procedures for the inpatient stayThese codes, along with patient’s demographic information, are grouped by decision trees (this process is computerized) into a specific DRGCMS assigns a weight to each DRG based on a variety of factors (e.g., diagnosis severity, procedures performed)CMS calculates a rate based on characteristics of the facility and assigns it to the DRG",
                    "sub_points": [
                      "Diagnosis-related groups (DRGs) make up a patient classification system used to reimburse inpatient ('Part A') hospital costs for Medicare patients",
                      "Although costs associated with inpatient clinical laboratory tests are included in the DRG, it does not cover physician services ('Part B')",
                      "After Medicare patient has been discharged from the hospital, the patient’s medical record is reviewed by health information management coders and is assigned appropriate ICD-9-CM and Healthcare Common Procedure Coding System (HCPCS) codes for 1 or more diagnoses and procedures for the inpatient stayThese codes, along with patient’s demographic information, are grouped by decision trees (this process is computerized) into a specific DRGCMS assigns a weight to each DRG based on a variety of factors (e.g., diagnosis severity, procedures performed)CMS calculates a rate based on characteristics of the facility and assigns it to the DRG",
                      "These codes, along with patient’s demographic information, are grouped by decision trees (this process is computerized) into a specific DRG",
                      "CMS assigns a weight to each DRG based on a variety of factors (e.g., diagnosis severity, procedures performed)",
                      "CMS calculates a rate based on characteristics of the facility and assigns it to the DRG"
                    ]
                  },
                  {
                    "text": "Medicare outpatientsCMS started to implement an outpatient prospective payment system with introduction of the Ambulatory Payment Classification (APC) system in 2000Under this system, virtually all hospital-based outpatient services (e.g., emergency department and clinic visits, oncology treatment and surgery) provided to Medicare patients are reimbursed on a prospective basis according to a preset rate (similar to DRGs)Clinical diagnostic laboratory tests are not currently included in the APC and are still reimbursed individually on the basis of the CMS fee schedule (with some exceptions)Advanced Beneficiary Notice (ABN) of noncoverageUnder certain conditions, Medicare does not pay for laboratory testsIf a laboratory expects Medicare to deny payment because a test does not meet medical necessity requirements, it must inform the patient before the service is providedABN is used to document that the beneficiary was told that the test might not be covered by Medicare, the reason(s) for the possible denial, and the decision by the patient to pay for the test if Medicare does not reimburse, or to refuse the test entirely",
                    "sub_points": [
                      "CMS started to implement an outpatient prospective payment system with introduction of the Ambulatory Payment Classification (APC) system in 2000Under this system, virtually all hospital-based outpatient services (e.g., emergency department and clinic visits, oncology treatment and surgery) provided to Medicare patients are reimbursed on a prospective basis according to a preset rate (similar to DRGs)Clinical diagnostic laboratory tests are not currently included in the APC and are still reimbursed individually on the basis of the CMS fee schedule (with some exceptions)",
                      "Under this system, virtually all hospital-based outpatient services (e.g., emergency department and clinic visits, oncology treatment and surgery) provided to Medicare patients are reimbursed on a prospective basis according to a preset rate (similar to DRGs)",
                      "Clinical diagnostic laboratory tests are not currently included in the APC and are still reimbursed individually on the basis of the CMS fee schedule (with some exceptions)",
                      "Advanced Beneficiary Notice (ABN) of noncoverageUnder certain conditions, Medicare does not pay for laboratory testsIf a laboratory expects Medicare to deny payment because a test does not meet medical necessity requirements, it must inform the patient before the service is providedABN is used to document that the beneficiary was told that the test might not be covered by Medicare, the reason(s) for the possible denial, and the decision by the patient to pay for the test if Medicare does not reimburse, or to refuse the test entirely",
                      "Under certain conditions, Medicare does not pay for laboratory tests",
                      "If a laboratory expects Medicare to deny payment because a test does not meet medical necessity requirements, it must inform the patient before the service is provided",
                      "ABN is used to document that the beneficiary was told that the test might not be covered by Medicare, the reason(s) for the possible denial, and the decision by the patient to pay for the test if Medicare does not reimburse, or to refuse the test entirely"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "National Institute of Science and Technology (NIST)": {
            "name": "National Institute of Science and Technology (NIST)",
            "url": "https://app.pathprimer.com/document/c9a91dd7-2cb8-4ac1-bd0f-bd0917b8d54a/lesson/4ab197e7-eaee-44a2-91a6-2e427e199ae5",
            "content": {
              "KEY CONCEPTS": {
                "Laboratory Regulation": [
                  {
                    "text": "NIST develops and distributes standardized calibration materials for finite list of analytes"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Food and Drug Administration (FDA)"
                  },
                  {
                    "text": "Department of Health and Human Services (HHS)"
                  },
                  {
                    "text": "National Institutes of Health (NIH)"
                  },
                  {
                    "text": "Centers for Medicare and Medicaid Services (CMS)"
                  },
                  {
                    "text": "National Institute of Standards and Technology (NIST)"
                  },
                  {
                    "text": "Office of Inspector General (OIG)"
                  }
                ]
              },
              "LABORATORY REGULATION": {
                "Regulatory Governmental Agencies": [
                  {
                    "text": "FDAPart of HHSRegulates manufacture of biologics, medical devices, test kits, and other things",
                    "sub_points": [
                      "Part of HHS",
                      "Regulates manufacture of biologics, medical devices, test kits, and other things"
                    ]
                  },
                  {
                    "text": "NIHAgency of HHSMain aim is performance and funding of biomedical research",
                    "sub_points": [
                      "Agency of HHS",
                      "Main aim is performance and funding of biomedical research"
                    ]
                  },
                  {
                    "text": "CMSSets quality standards and reimbursement rates that apply to laboratoriesRates often adopted by third-party payers",
                    "sub_points": [
                      "Sets quality standards and reimbursement rates that apply to laboratories",
                      "Rates often adopted by third-party payers"
                    ]
                  },
                  {
                    "text": "NISTBranch of Department of CommerceDevelops and distributes standardized calibration materials for finite list of analytesDevelops standardized materials for calibration, weights, and measures",
                    "sub_points": [
                      "Branch of Department of Commerce",
                      "Develops and distributes standardized calibration materials for finite list of analytes",
                      "Develops standardized materials for calibration, weights, and measures"
                    ]
                  },
                  {
                    "text": "HHS oversees CMS, FDA, and OIG"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Occupational Safety and Health Administration (OSHA) Regulations": {
            "name": "Occupational Safety and Health Administration (OSHA) Regulations",
            "url": "https://app.pathprimer.com/document/3f3fea08-1b65-469b-878d-5ec66399344d/lesson/4ab197e7-eaee-44a2-91a6-2e427e199ae5",
            "content": {
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Occupational Safety and Health Administration (OSHA)"
                  }
                ]
              },
              "LABORATORY REGULATION": {
                "Overview": [
                  {
                    "text": "OSHA was passed by Congress in 1970 and requires employers to provide a safe workplace"
                  },
                  {
                    "text": "OSHA, which enforces the Occupational Safety and Health Act, is part of US Department of Labor"
                  },
                  {
                    "text": "OSHA standards are rules that employers must follow to protect employees from hazardsLimit hazardous chemical exposureRequire certain safety practices and equipment (e.g., universal precautions)Require monitoring of hazardsRequire keeping records of workplace injuriesRequire employers to display poster prepared by Department of Labor that informs employees of their protections under Occupational Safety and Health Act",
                    "sub_points": [
                      "Limit hazardous chemical exposure",
                      "Require certain safety practices and equipment (e.g., universal precautions)",
                      "Require monitoring of hazards",
                      "Require keeping records of workplace injuries",
                      "Require employers to display poster prepared by Department of Labor that informs employees of their protections under Occupational Safety and Health Act"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Proficiency Testing": {
            "name": "Proficiency Testing",
            "url": "https://app.pathprimer.com/document/3a4aa7d8-31d2-44d0-948a-148c7d1bfa2b/lesson/4ab197e7-eaee-44a2-91a6-2e427e199ae5",
            "content": {
              "KEY CONCEPTS": {
                "Quality": [
                  {
                    "text": "PT involves testing samples with quantity unknown to laboratory and then comparing results across laboratories that use similar methodology"
                  },
                  {
                    "text": "PT ensures accuracy and reliability of laboratory testing"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Centers for Medicare and Medicaid Services (CMS)"
                  },
                  {
                    "text": "Clinical Laboratory Improvement Amendments (CLIA)"
                  },
                  {
                    "text": "Proficiency testing (PT)"
                  },
                  {
                    "text": "US Food and Drug Administration (FDA)"
                  }
                ]
              },
              "QUALITY": {
                "Proficiency Testing": [
                  {
                    "text": "Involves testing samples with quantity unknown to laboratory and then comparing results across laboratories that use similar methodologyProficiency samples should be tested in same manner as patient samplesProficiency samples cannot be sent to reference laboratories for result correlationLaboratories should not discuss test results with other laboratories prior to submission deadline",
                    "sub_points": [
                      "Proficiency samples should be tested in same manner as patient samples",
                      "Proficiency samples cannot be sent to reference laboratories for result correlation",
                      "Laboratories should not discuss test results with other laboratories prior to submission deadline"
                    ]
                  },
                  {
                    "text": "Purpose is to ensure accuracy and reliability of laboratory with regard to other laboratories performing the same or comparable assaysDelta checksCompare current result values with previous result values for a given patientFlag samples that have exceeded predefined acceptable limits for variationDetect either preanalytical or analytical errors in testingSpecimen mix-up errorsDiluted samplesAnalyzer malfunction",
                    "sub_points": [
                      "Delta checksCompare current result values with previous result values for a given patientFlag samples that have exceeded predefined acceptable limits for variationDetect either preanalytical or analytical errors in testingSpecimen mix-up errorsDiluted samplesAnalyzer malfunction",
                      "Compare current result values with previous result values for a given patient",
                      "Flag samples that have exceeded predefined acceptable limits for variation",
                      "Detect either preanalytical or analytical errors in testingSpecimen mix-up errorsDiluted samplesAnalyzer malfunction",
                      "Specimen mix-up errors",
                      "Diluted samples",
                      "Analyzer malfunction"
                    ]
                  },
                  {
                    "text": "PT samplesShould be treated just like routine patient samplesShould never be sent out to another laboratory even if protocol calls for reflex testing at outside laboratory",
                    "sub_points": [
                      "Should be treated just like routine patient samples",
                      "Should never be sent out to another laboratory even if protocol calls for reflex testing at outside laboratory"
                    ]
                  }
                ],
                "Regulatory Considerations": [
                  {
                    "text": "CMS provides list of approved PT programs in which laboratory can enroll to meet PT regulatory criteria"
                  },
                  {
                    "text": "CLIA certificationTo maintain CLIA certificate, laboratory must participate in CLIA-approved PT program for all regulated moderate- and high-complexity tests performed under the CLIA certificateIf a moderate- or high-complexity analyte does not fall under “regulated” category established by CLIA, laboratory must establish semiannual program by which accuracy and reliability are checkedUnsuccessful performance/participation in PT means repeated unsatisfactory test scores for an analyte, or for entire testing event in particular specialty or subspecialty, on 2 consecutive PT events or on 2 of 3 testing eventsUnsatisfactory performance in PT means failure to attain minimum satisfactory score for an analyte, test, subspecialty, or specialty for a testing eventClerical errors in entering PT results are counted as incorrect results and, therefore, as unsatisfactory performance for the analyte in questionFailure to report results of PT within allotted time frame will cause laboratory to receive score of 0 for that eventIf laboratory receives nonpassing score for an analyte, laboratory must investigate cause of error and consider, implement, and document corrective actions",
                    "sub_points": [
                      "To maintain CLIA certificate, laboratory must participate in CLIA-approved PT program for all regulated moderate- and high-complexity tests performed under the CLIA certificateIf a moderate- or high-complexity analyte does not fall under “regulated” category established by CLIA, laboratory must establish semiannual program by which accuracy and reliability are checkedUnsuccessful performance/participation in PT means repeated unsatisfactory test scores for an analyte, or for entire testing event in particular specialty or subspecialty, on 2 consecutive PT events or on 2 of 3 testing eventsUnsatisfactory performance in PT means failure to attain minimum satisfactory score for an analyte, test, subspecialty, or specialty for a testing eventClerical errors in entering PT results are counted as incorrect results and, therefore, as unsatisfactory performance for the analyte in questionFailure to report results of PT within allotted time frame will cause laboratory to receive score of 0 for that eventIf laboratory receives nonpassing score for an analyte, laboratory must investigate cause of error and consider, implement, and document corrective actions",
                      "If a moderate- or high-complexity analyte does not fall under “regulated” category established by CLIA, laboratory must establish semiannual program by which accuracy and reliability are checked",
                      "Unsuccessful performance/participation in PT means repeated unsatisfactory test scores for an analyte, or for entire testing event in particular specialty or subspecialty, on 2 consecutive PT events or on 2 of 3 testing eventsUnsatisfactory performance in PT means failure to attain minimum satisfactory score for an analyte, test, subspecialty, or specialty for a testing eventClerical errors in entering PT results are counted as incorrect results and, therefore, as unsatisfactory performance for the analyte in questionFailure to report results of PT within allotted time frame will cause laboratory to receive score of 0 for that eventIf laboratory receives nonpassing score for an analyte, laboratory must investigate cause of error and consider, implement, and document corrective actions",
                      "Unsatisfactory performance in PT means failure to attain minimum satisfactory score for an analyte, test, subspecialty, or specialty for a testing event",
                      "Clerical errors in entering PT results are counted as incorrect results and, therefore, as unsatisfactory performance for the analyte in question",
                      "Failure to report results of PT within allotted time frame will cause laboratory to receive score of 0 for that event",
                      "If laboratory receives nonpassing score for an analyte, laboratory must investigate cause of error and consider, implement, and document corrective actions"
                    ]
                  },
                  {
                    "text": "FDA-waived tests need not participate in PT programs"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Stark Law": {
            "name": "Stark Law",
            "url": "https://app.pathprimer.com/document/2fda4ee9-82a7-4023-a2be-40e029708e22/lesson/4ab197e7-eaee-44a2-91a6-2e427e199ae5",
            "content": {
              "KEY CONCEPTS": {
                "Laboratory Regulation": [
                  {
                    "text": "Stark Law makes it illegal to bill Medicare (or anyone else) for designated health services that are result of prohibited referral"
                  }
                ]
              },
              "LABORATORY REGULATION": {
                "Stark Law Enacted in 1989": [
                  {
                    "text": "Enacted to address potential financial conflicts of interest that result from physicians referring patients to laboratory or clinical services from which they (or close family members) benefit"
                  },
                  {
                    "text": "Illegal to bill Medicare (or anyone else) for designated health services that are result of prohibited referralDesignated health servicesClinical laboratory servicesPhysical and occupational therapy servicesOutpatient speech-language pathology servicesRadiology servicesRadiation therapy servicesDurable medical equipment and suppliesParenteral/enteral nutrients and suppliesOrthotics and prosthetic devices and suppliesHome health servicesOutpatient prescription drugsInpatient and outpatient hospital services",
                    "sub_points": [
                      "Designated health servicesClinical laboratory servicesPhysical and occupational therapy servicesOutpatient speech-language pathology servicesRadiology servicesRadiation therapy servicesDurable medical equipment and suppliesParenteral/enteral nutrients and suppliesOrthotics and prosthetic devices and suppliesHome health servicesOutpatient prescription drugsInpatient and outpatient hospital services",
                      "Clinical laboratory services",
                      "Physical and occupational therapy services",
                      "Outpatient speech-language pathology services",
                      "Radiology services",
                      "Radiation therapy services",
                      "Durable medical equipment and supplies",
                      "Parenteral/enteral nutrients and supplies",
                      "Orthotics and prosthetic devices and supplies",
                      "Home health services",
                      "Outpatient prescription drugs",
                      "Inpatient and outpatient hospital services"
                    ]
                  },
                  {
                    "text": "If payments are issued, entity in question must refund all payments associated with prohibited referral(s)Example of prohibited referral: Physician sending Medicare patients to laboratories in which physician or close family member may have financial interest\"Safe harbor\" laws exist that may allow legitimate self-referral",
                    "sub_points": [
                      "Example of prohibited referral: Physician sending Medicare patients to laboratories in which physician or close family member may have financial interest",
                      "\"Safe harbor\" laws exist that may allow legitimate self-referral"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "College of American Pathologists (CAP) Competency Testing": {
            "name": "College of American Pathologists (CAP) Competency Testing",
            "url": "https://app.pathprimer.com/document/50a319af-e0d7-4f4b-8750-73d47e018614/lesson/4ab197e7-eaee-44a2-91a6-2e427e199ae5",
            "content": {
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "College of American Pathologists (CAP)"
                  },
                  {
                    "text": "Clinical Laboratory Improvement Amendments (CLIA)"
                  },
                  {
                    "text": "Center of Medicare and Medicaid Services (CMS)"
                  }
                ]
              },
              "LABORATORY REGULATION": {
                "CAP Laboratory Accreditation Program": [
                  {
                    "text": "CAP offers program that routinely inspects laboratories on 2-year cycle"
                  },
                  {
                    "text": "CLIA-accredited laboratory has been inspected by accrediting organizations approved by CMS"
                  },
                  {
                    "text": "Approved accrediting organization can inspect laboratory in lieu of CMSCMS has granted CAP Laboratory Accreditation Program deeming authority",
                    "sub_points": [
                      "CMS has granted CAP Laboratory Accreditation Program deeming authority"
                    ]
                  },
                  {
                    "text": "CAP inspections are unannounced, occurring within 3-month window of anniversary date of laboratory's first CAP inspection"
                  },
                  {
                    "text": "CAP inspections are guided by detailed checklists created for different areas of laboratoryChecklists provided by CAP designate citations as Phase I or Phase IIPhase II is more serious, requiring corrective action, documentation supporting corrective action, and follow-up report to CAP within 30 days",
                    "sub_points": [
                      "Checklists provided by CAP designate citations as Phase I or Phase IIPhase II is more serious, requiring corrective action, documentation supporting corrective action, and follow-up report to CAP within 30 days",
                      "Phase II is more serious, requiring corrective action, documentation supporting corrective action, and follow-up report to CAP within 30 days"
                    ]
                  },
                  {
                    "text": "Peer-based inspection model uses teams of practicing professionals qualified through training program"
                  },
                  {
                    "text": "Program is available for laboratories in United States and internationally"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Health Insurance Portability and Accountability Act (HIPAA)": {
            "name": "Health Insurance Portability and Accountability Act (HIPAA)",
            "url": "https://app.pathprimer.com/document/2906a4e2-0552-4928-abe2-4cd6acb2e4ed/lesson/4ab197e7-eaee-44a2-91a6-2e427e199ae5",
            "content": {
              "KEY CONCEPTS": {
                "Laboratory Regulation": [
                  {
                    "text": "Privacy Rule establishes set of national standards for protection of certain health information"
                  },
                  {
                    "text": "Security Rule establishes national set of security standards for protecting certain health information held or transferred in electronic form"
                  }
                ]
              },
              "OVERVIEW": {
                "History": [
                  {
                    "text": "Established in 1996"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Electronic protected health information (e-PHI)"
                  },
                  {
                    "text": "Protected health information (PHI)"
                  },
                  {
                    "text": "Institutional Review Board (IRB)"
                  },
                  {
                    "text": "Health and Human Services (HHS)"
                  },
                  {
                    "text": "Food and Drug Administration (FDA)"
                  }
                ]
              },
              "LABORATORY REGULATION": {
                "﻿Standards for Privacy of Individually Identifiable Health Information (“Privacy Rule”)": [
                  {
                    "text": "Establishes, for first time, set of national standards for protection of certain health information"
                  },
                  {
                    "text": "Sets national standards for protection of individually identifiable health information by 3 types of covered entitiesHealth plansHealth care clearinghousesHealth care providers who conduct standard health care transactions electronically",
                    "sub_points": [
                      "Health plans",
                      "Health care clearinghouses",
                      "Health care providers who conduct standard health care transactions electronically"
                    ]
                  },
                  {
                    "text": "What information is protectedProtects all \"individually identifiable health information\" held or transmitted by covered entity or its business associateIn any form or media, whether electronic, paper, or oralPrivacy Rule calls this information \"protected health information\" (PHI)Individual’s past, present, or future physical or mental health or conditionProvision of health care to individualPast, present, or future payment for provision of health care to individual that identifies individual or for which there is reasonable basis to believe it can be used to identify individual",
                    "sub_points": [
                      "Protects all \"individually identifiable health information\" held or transmitted by covered entity or its business associateIn any form or media, whether electronic, paper, or oralPrivacy Rule calls this information \"protected health information\" (PHI)",
                      "In any form or media, whether electronic, paper, or oral",
                      "Privacy Rule calls this information \"protected health information\" (PHI)",
                      "Individual’s past, present, or future physical or mental health or condition",
                      "Provision of health care to individual",
                      "Past, present, or future payment for provision of health care to individual that identifies individual or for which there is reasonable basis to believe it can be used to identify individual"
                    ]
                  },
                  {
                    "text": "Individually identifiable health information includes many common identifiers (e.g., name, address, birth date, social security number)"
                  },
                  {
                    "text": "Privacy Rule excludes from PHI employment records that covered entity maintains in its capacity as employer and education and certain other records subject to, or defined in, Family Educational Rights and Privacy Act"
                  },
                  {
                    "text": "No restrictions on use or disclosure of de-identified health informationDe-identified health information neither identifies nor provides reasonable basis to identify individual",
                    "sub_points": [
                      "De-identified health information neither identifies nor provides reasonable basis to identify individual"
                    ]
                  },
                  {
                    "text": "Institutional Review Boards and the Privacy RuleIRB is a board, committee, or other group formally designated by an academic institution (usually) to review research involving humans as subjectsHospitals, academic medical centers, government units, and others engaged in federally conducted or supported health research activities involving human subjects, and entities conducting FDA-regulated clinical investigations, (among others) have designated IRBsIRBs have authority to approve, require modification to, or disapprove all research activities covered by HHS and FDA Protection of Human Subjects RegulationsEvery institution engaged in human subjects research conducted or supported by federal department or agency that has adopted the Common Rule (Federal Policy for the Protection of Human Subjects) is required to designate one or more IRBs under an assurance of complianceFollowing initial approval, IRBs must conduct periodic reviews of such researchIn most instances, in order to approve research, an IRB must determine that specified criteria have been satisfiedAmong these criteria, an IRB must determine that, when appropriate, the research protocol includes \"adequate provisions to protect the privacy of subjects and to maintain the confidentiality of data\"Beginning on April 14, 2003, the Privacy Rule's compliance date for most covered entities, IRBs gained authority to consider, and act upon, requests for a partial or complete waiver or alteration of the Privacy Rule's Authorization requirement for uses and disclosures of PHI for researchAlthough HHS and FDA Protection of Human Subjects Regulations include protections to help ensure the privacy of subjects and the confidentiality of information, the Privacy Rule supplements these protections by requiring covered entities to implement specific measures to safeguard the privacy of PHIIf certain conditions are met, an IRB may grant a waiver or an alteration of the Authorization requirement for research uses or disclosures of PHI",
                    "sub_points": [
                      "IRB is a board, committee, or other group formally designated by an academic institution (usually) to review research involving humans as subjects",
                      "Hospitals, academic medical centers, government units, and others engaged in federally conducted or supported health research activities involving human subjects, and entities conducting FDA-regulated clinical investigations, (among others) have designated IRBs",
                      "IRBs have authority to approve, require modification to, or disapprove all research activities covered by HHS and FDA Protection of Human Subjects Regulations",
                      "Every institution engaged in human subjects research conducted or supported by federal department or agency that has adopted the Common Rule (Federal Policy for the Protection of Human Subjects) is required to designate one or more IRBs under an assurance of compliance",
                      "Following initial approval, IRBs must conduct periodic reviews of such research",
                      "In most instances, in order to approve research, an IRB must determine that specified criteria have been satisfiedAmong these criteria, an IRB must determine that, when appropriate, the research protocol includes \"adequate provisions to protect the privacy of subjects and to maintain the confidentiality of data\"",
                      "Among these criteria, an IRB must determine that, when appropriate, the research protocol includes \"adequate provisions to protect the privacy of subjects and to maintain the confidentiality of data\"",
                      "Beginning on April 14, 2003, the Privacy Rule's compliance date for most covered entities, IRBs gained authority to consider, and act upon, requests for a partial or complete waiver or alteration of the Privacy Rule's Authorization requirement for uses and disclosures of PHI for researchAlthough HHS and FDA Protection of Human Subjects Regulations include protections to help ensure the privacy of subjects and the confidentiality of information, the Privacy Rule supplements these protections by requiring covered entities to implement specific measures to safeguard the privacy of PHIIf certain conditions are met, an IRB may grant a waiver or an alteration of the Authorization requirement for research uses or disclosures of PHI",
                      "Although HHS and FDA Protection of Human Subjects Regulations include protections to help ensure the privacy of subjects and the confidentiality of information, the Privacy Rule supplements these protections by requiring covered entities to implement specific measures to safeguard the privacy of PHI",
                      "If certain conditions are met, an IRB may grant a waiver or an alteration of the Authorization requirement for research uses or disclosures of PHI"
                    ]
                  }
                ],
                "Security Standards for Protection of Electronic PHI (\"Security Rule\")": [
                  {
                    "text": "Establishes national set of security standards for protecting certain health information held or transferred in electronic form"
                  },
                  {
                    "text": "Pathology laboratories are legally required to securely acquire, analyze, store, and transmit electronic data of the patient"
                  },
                  {
                    "text": "General rules(1) Ensure confidentiality, integrity, and availability of all e-PHI created, received, maintained, or transmitted by covered entitiesConfidentiality: Means e-PHI is not available or disclosed to unauthorized personsIntegrity: Means e-PHI is not altered or destroyed in an unauthorized mannerAvailability: Means e-PHI is accessible and usable on demand by authorized person(2) Identify and protect against reasonably anticipated threats to security or integrity of information(3) Protect against reasonably anticipated, impermissible uses or disclosures(4) Ensure compliance by their workforce",
                    "sub_points": [
                      "(1) Ensure confidentiality, integrity, and availability of all e-PHI created, received, maintained, or transmitted by covered entitiesConfidentiality: Means e-PHI is not available or disclosed to unauthorized personsIntegrity: Means e-PHI is not altered or destroyed in an unauthorized mannerAvailability: Means e-PHI is accessible and usable on demand by authorized person",
                      "Confidentiality: Means e-PHI is not available or disclosed to unauthorized persons",
                      "Integrity: Means e-PHI is not altered or destroyed in an unauthorized manner",
                      "Availability: Means e-PHI is accessible and usable on demand by authorized person",
                      "(2) Identify and protect against reasonably anticipated threats to security or integrity of information",
                      "(3) Protect against reasonably anticipated, impermissible uses or disclosures",
                      "(4) Ensure compliance by their workforce"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Safeguards for Strengthening Security": {
            "name": "Safeguards for Strengthening Security",
            "url": "https://app.pathprimer.com/document/dfe14a2a-8e43-4cb0-9422-7ec4ae3610f4/lesson/4ab197e7-eaee-44a2-91a6-2e427e199ae5",
            "content": {
              "KEY CONCEPTS": {
                "Laboratory Informatics": [
                  {
                    "text": "Administrative safeguards provisions in Security Rule of HIPAA require covered entities to perform risk analysis as part of their security management processes"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Electronic protected health information (e-PHI)"
                  },
                  {
                    "text": "Health Insurance Portability and Accountability Act (HIPAA)"
                  }
                ]
              },
              "LABORATORY INFORMATICS": {
                "Risk Analysis and Management": [
                  {
                    "text": "Administrative safeguards provisions in Security Rule of HIPAA require covered entities to perform risk analysis as part of their security management processes"
                  },
                  {
                    "text": "Risk analysis affects implementation of all safeguards contained in Security Rule"
                  }
                ],
                "Safeguards": [
                  {
                    "text": "Administrative safeguardsSecurity management processCovered entity must identify and analyze potential risks to e-PHIMust implement security measures that reduce risks and vulnerabilities to reasonable and appropriate levelSecurity personnelCovered entity must designate security official who is responsible for developing and implementing its security policies and proceduresInformation access managementCovered entity is required to implement policies and procedures for authorizing access to e-PHI only when such access is appropriate based on user or recipient's roleRole-based accessWorkforce training and managementCovered entity must provide for appropriate authorization and supervision of workforce members who work with e-PHIMust train all workforce members regarding its security policies and proceduresMust have and apply appropriate sanctions against workforce members who violate its policies and proceduresEvaluationCovered entity must perform periodic assessment of how well its security policies and procedures meet requirements of Security Rule",
                    "sub_points": [
                      "Security management processCovered entity must identify and analyze potential risks to e-PHIMust implement security measures that reduce risks and vulnerabilities to reasonable and appropriate level",
                      "Covered entity must identify and analyze potential risks to e-PHI",
                      "Must implement security measures that reduce risks and vulnerabilities to reasonable and appropriate level",
                      "Security personnelCovered entity must designate security official who is responsible for developing and implementing its security policies and procedures",
                      "Covered entity must designate security official who is responsible for developing and implementing its security policies and procedures",
                      "Information access managementCovered entity is required to implement policies and procedures for authorizing access to e-PHI only when such access is appropriate based on user or recipient's roleRole-based access",
                      "Covered entity is required to implement policies and procedures for authorizing access to e-PHI only when such access is appropriate based on user or recipient's roleRole-based access",
                      "Role-based access",
                      "Workforce training and managementCovered entity must provide for appropriate authorization and supervision of workforce members who work with e-PHIMust train all workforce members regarding its security policies and proceduresMust have and apply appropriate sanctions against workforce members who violate its policies and procedures",
                      "Covered entity must provide for appropriate authorization and supervision of workforce members who work with e-PHI",
                      "Must train all workforce members regarding its security policies and procedures",
                      "Must have and apply appropriate sanctions against workforce members who violate its policies and procedures",
                      "EvaluationCovered entity must perform periodic assessment of how well its security policies and procedures meet requirements of Security Rule",
                      "Covered entity must perform periodic assessment of how well its security policies and procedures meet requirements of Security Rule"
                    ]
                  },
                  {
                    "text": "Physical safeguardsFacility access and controlCovered entity must limit physical access to its facilities while ensuring authorized access is allowedWork station and device securityCovered entity must implement policies and procedures to specify proper use of and access to work stations and electronic mediaCovered entity also must have in place policies and procedures regarding transfer, removal, disposal, and re-use of electronic media, to ensure appropriate protection of e-PHI",
                    "sub_points": [
                      "Facility access and controlCovered entity must limit physical access to its facilities while ensuring authorized access is allowed",
                      "Covered entity must limit physical access to its facilities while ensuring authorized access is allowed",
                      "Work station and device securityCovered entity must implement policies and procedures to specify proper use of and access to work stations and electronic mediaCovered entity also must have in place policies and procedures regarding transfer, removal, disposal, and re-use of electronic media, to ensure appropriate protection of e-PHI",
                      "Covered entity must implement policies and procedures to specify proper use of and access to work stations and electronic media",
                      "Covered entity also must have in place policies and procedures regarding transfer, removal, disposal, and re-use of electronic media, to ensure appropriate protection of e-PHI"
                    ]
                  },
                  {
                    "text": "Technical safeguardsAccess controlCovered entity must implement technical policies and procedures that allow only authorized persons to access e-PHIAudit controlsCovered entity must implement hardware, software, &/or procedural mechanisms to record and examine access and other activity in information systems that contain or use e-PHIIntegrity controlsCovered entity must implement policies and procedures to ensure that e-PHI is not improperly altered or destroyedElectronic measures must be put in place to confirm that e-PHI has not been improperly altered or destroyedTransmission securityCovered entity must implement technical security measures that guard against unauthorized access to e-PHI that is being transmitted over electronic network",
                    "sub_points": [
                      "Access controlCovered entity must implement technical policies and procedures that allow only authorized persons to access e-PHI",
                      "Covered entity must implement technical policies and procedures that allow only authorized persons to access e-PHI",
                      "Audit controlsCovered entity must implement hardware, software, &/or procedural mechanisms to record and examine access and other activity in information systems that contain or use e-PHI",
                      "Covered entity must implement hardware, software, &/or procedural mechanisms to record and examine access and other activity in information systems that contain or use e-PHI",
                      "Integrity controlsCovered entity must implement policies and procedures to ensure that e-PHI is not improperly altered or destroyedElectronic measures must be put in place to confirm that e-PHI has not been improperly altered or destroyed",
                      "Covered entity must implement policies and procedures to ensure that e-PHI is not improperly altered or destroyed",
                      "Electronic measures must be put in place to confirm that e-PHI has not been improperly altered or destroyed",
                      "Transmission securityCovered entity must implement technical security measures that guard against unauthorized access to e-PHI that is being transmitted over electronic network",
                      "Covered entity must implement technical security measures that guard against unauthorized access to e-PHI that is being transmitted over electronic network"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          }
        }
      },
      "Computer Basics": {
        "name": "Computer Basics",
        "url": "https://app.pathprimer.com/lesson/bb7d05fb-2cf8-468e-97df-e92fe85d3b91",
        "topics": {
          "Computer Networking": {
            "name": "Computer Networking",
            "url": "https://app.pathprimer.com/document/9407b06d-e866-4614-a7b9-78be34a8d697/lesson/bb7d05fb-2cf8-468e-97df-e92fe85d3b91",
            "content": {
              "KEY CONCEPTS": {
                "Laboratory Informatics": [
                  {
                    "text": "﻿Network: Interconnected group of computers that share information and resourcesPertaining to a laboratory, the ability to obtain orders from and send results to other information systems",
                    "sub_points": [
                      "Pertaining to a laboratory, the ability to obtain orders from and send results to other information systems"
                    ]
                  },
                  {
                    "text": "Internet: Worldwide, publicly accessible series of interconnected computer networks"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Hypertext markup language (HTML)"
                  },
                  {
                    "text": "Internet protocol (IP)"
                  },
                  {
                    "text": "Local area network (LAN)"
                  },
                  {
                    "text": "Virtual private network (VPN)"
                  },
                  {
                    "text": "Wide area network (WAN)"
                  },
                  {
                    "text": "World Wide Web (www)"
                  }
                ]
              },
              "LABORATORY INFORMATICS": {
                "Terms and Definitions": [
                  {
                    "text": "Network: Interconnected group of computers that share information and resourcesPertaining to a laboratory, the ability to obtain orders from and send results to other information systemsMost computers need a card or adapter to connect to networkEthernet is the most common type of networking standardNetwork componentsModem (“modulator-demodulator”): Modulates analog carrier signal to encode digital informationRouter: Routes and forwards informationServer: Accepts connections to service requests by sending back responsesClient: Application or system that accesses a serverFirewall: Device &/or software that inspects network traffic passing through it and denies or permits passage based on a set of rulesNetwork typesLAN: Covers a small geographic areaWAN: Covers a broad geographic area",
                    "sub_points": [
                      "Pertaining to a laboratory, the ability to obtain orders from and send results to other information systems",
                      "Most computers need a card or adapter to connect to networkEthernet is the most common type of networking standard",
                      "Ethernet is the most common type of networking standard",
                      "Network componentsModem (“modulator-demodulator”): Modulates analog carrier signal to encode digital informationRouter: Routes and forwards informationServer: Accepts connections to service requests by sending back responsesClient: Application or system that accesses a serverFirewall: Device &/or software that inspects network traffic passing through it and denies or permits passage based on a set of rules",
                      "Modem (“modulator-demodulator”): Modulates analog carrier signal to encode digital information",
                      "Router: Routes and forwards information",
                      "Server: Accepts connections to service requests by sending back responses",
                      "Client: Application or system that accesses a server",
                      "Firewall: Device &/or software that inspects network traffic passing through it and denies or permits passage based on a set of rules",
                      "Network typesLAN: Covers a small geographic areaWAN: Covers a broad geographic area",
                      "LAN: Covers a small geographic area",
                      "WAN: Covers a broad geographic area"
                    ]
                  },
                  {
                    "text": "Bandwidth: Rate of data transmission"
                  },
                  {
                    "text": "Internet: Worldwide, publicly accessible series of interconnected computer networksData transmitted by packet switching using standard Internet protocol (IP)",
                    "sub_points": [
                      "Data transmitted by packet switching using standard Internet protocol (IP)"
                    ]
                  },
                  {
                    "text": "World Wide Web (www): Hypertext-based data system that uses the Internet as its transportationHypertext: Text on a computer that leads a user, on demand, to other related informationHypertext markup language (HTML): Language most commonly used to specify the appearance of a web page when interpreted by web browser",
                    "sub_points": [
                      "Hypertext: Text on a computer that leads a user, on demand, to other related information",
                      "Hypertext markup language (HTML): Language most commonly used to specify the appearance of a web page when interpreted by web browser"
                    ]
                  },
                  {
                    "text": "Intranet: Private network that uses aforementioned IPs to share information within an organization as opposed to between separate entities"
                  },
                  {
                    "text": "Data security: Paramount for all networksEncryption: Conversion of data via an algorithm that rearranges bits that cannot be deciphered without decryptionVirtual private network (VPN): Method by which a user can access an organization's internal network securely over the InternetSoftware layer applied on top of existing network, essentially creating virtual \"tunnels\" that wrap data packets destined for the internal network and then encrypting those packets to send across the InternetProvides users who are not on that internal network secure access to resources inside it",
                    "sub_points": [
                      "Encryption: Conversion of data via an algorithm that rearranges bits that cannot be deciphered without decryption",
                      "Virtual private network (VPN): Method by which a user can access an organization's internal network securely over the InternetSoftware layer applied on top of existing network, essentially creating virtual \"tunnels\" that wrap data packets destined for the internal network and then encrypting those packets to send across the InternetProvides users who are not on that internal network secure access to resources inside it",
                      "Software layer applied on top of existing network, essentially creating virtual \"tunnels\" that wrap data packets destined for the internal network and then encrypting those packets to send across the Internet",
                      "Provides users who are not on that internal network secure access to resources inside it"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Operating Systems and Programming Languages": {
            "name": "Operating Systems and Programming Languages",
            "url": "https://app.pathprimer.com/document/d164ec06-51de-4e97-9844-82f959fa3a7d/lesson/bb7d05fb-2cf8-468e-97df-e92fe85d3b91",
            "content": {
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Operating system (OS)"
                  }
                ]
              },
              "LABORATORY INFORMATICS": {
                "Operating System": [
                  {
                    "text": "OS of a device (whether computer or analyzer): Set of programs responsible for management and coordination of activities and sharing of resourcesActs as host for application programs",
                    "sub_points": [
                      "Acts as host for application programs"
                    ]
                  },
                  {
                    "text": "Drivers: Small files that are specific to an OS that allow identification and utilization of various external peripherals and other devices"
                  }
                ],
                "Programming Language": [
                  {
                    "text": "Artificial language used to create applications that control computer behaviorCan be specific for hardware platform (e.g., BASIC, FORTRAN)Can be hardware-independent (e.g., Java)",
                    "sub_points": [
                      "Can be specific for hardware platform (e.g., BASIC, FORTRAN)",
                      "Can be hardware-independent (e.g., Java)"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Standards and Protocols": {
            "name": "Standards and Protocols",
            "url": "https://app.pathprimer.com/document/935a5c1a-987f-4abc-878a-359efffbf058/lesson/bb7d05fb-2cf8-468e-97df-e92fe85d3b91",
            "content": {
              "KEY CONCEPTS": {
                "Overview": [
                  {
                    "text": "Use of conventions and definitions to standardize information exchange between different systemsLess complex and time-consuming than traditional strategy of creating custom interfaces between applications",
                    "sub_points": [
                      "Less complex and time-consuming than traditional strategy of creating custom interfaces between applications"
                    ]
                  }
                ],
                "Terminology": [
                  {
                    "text": "HL7: Widely adopted protocol developed by the healthcare industry for electronic data exchange that specifies syntax and rules for messaging"
                  },
                  {
                    "text": "LOINC: Set of universal identifiers for laboratory test code data fields within HL7 messages and in databases"
                  }
                ]
              },
              "OVERVIEW": {
                "Basic Principles": [
                  {
                    "text": "Use of conventions and definitions to standardize information exchange between different systemsLess complex and time-consuming than traditional strategy of creating custom interfaces between applications",
                    "sub_points": [
                      "Less complex and time-consuming than traditional strategy of creating custom interfaces between applications"
                    ]
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "American Society for Testing and Materials (ASTM)"
                  },
                  {
                    "text": "College of American Pathologists (CAP)"
                  },
                  {
                    "text": "Current procedural terminology (CPT)"
                  },
                  {
                    "text": "Extensible markup language (XML)"
                  },
                  {
                    "text": "Health Level 7 (HL7)"
                  },
                  {
                    "text": "Logical Observation Identifier Names and Codes (LOINC)"
                  },
                  {
                    "text": "Systematic Nomenclature of Medicine – Clinical Terms (SNOMED-CT)"
                  }
                ],
                "Definitions": [
                  {
                    "text": "HL7: Widely adopted protocol developed by the healthcare industry for electronic data exchange, which specifies syntax and rules for messagingMost current version of HL7 (Version 3) uses messaging syntax based on XML",
                    "sub_points": [
                      "Most current version of HL7 (Version 3) uses messaging syntax based on XML"
                    ]
                  },
                  {
                    "text": "XML: Method to describe data, structure information, and format documents accomplished by using markup tags that describe the data marked by the tag"
                  },
                  {
                    "text": "LOINC: Set of universal identifiers for laboratory test code data fields within HL7 messages and in databasesProvides structured naming convention for describing laboratory testsFewer limitations than CPT",
                    "sub_points": [
                      "Provides structured naming convention for describing laboratory tests",
                      "Fewer limitations than CPT"
                    ]
                  },
                  {
                    "text": "ASTM: Specifies protocols and formats for instrument interfaces, barcodes, and other systems and components"
                  },
                  {
                    "text": "SNOMED-CT system: Elaborate nomenclature for medical conditions and related concepts that contains > 300,000 unique clinical conceptsOriginally developed by CAP, now maintained by International Healthcare Terminology Standards Development OrganizationReceiving systems may not recognize certain codes as written, so use of a translation table relates a code to its equivalent in that receiving system",
                    "sub_points": [
                      "Originally developed by CAP, now maintained by International Healthcare Terminology Standards Development Organization",
                      "Receiving systems may not recognize certain codes as written, so use of a translation table relates a code to its equivalent in that receiving system"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Storage Devices/Options": {
            "name": "Storage Devices/Options",
            "url": "https://app.pathprimer.com/document/d1c3a87f-7b98-4e50-9bea-2f8c6618b433/lesson/bb7d05fb-2cf8-468e-97df-e92fe85d3b91",
            "content": {
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Redundant array of independent/inexpensive disks (RAID)"
                  }
                ],
                "Definitions": [
                  {
                    "text": "StoragePhysical media that store data permanentlyInternal (e.g., hard drive)Removable (e.g., CD-ROM, USB drive)",
                    "sub_points": [
                      "Physical media that store data permanentlyInternal (e.g., hard drive)Removable (e.g., CD-ROM, USB drive)",
                      "Internal (e.g., hard drive)",
                      "Removable (e.g., CD-ROM, USB drive)"
                    ]
                  },
                  {
                    "text": "Many labs utilize drive arrays that are multiple hard drives configured to look like single-system driveRAIDCommon type of drive arraySimultaneously uses 2 or more hard-disk drives to achieve greater levels of performance, reliability, &/or larger data volume sizesMirrored drive arrayCopies of files are written to each drive in arrayDifferent parts of file are read simultaneously from different disks and “assembled” for deliverySystem is redundant (if one drive fails, file can be read from other intact drives)",
                    "sub_points": [
                      "RAIDCommon type of drive arraySimultaneously uses 2 or more hard-disk drives to achieve greater levels of performance, reliability, &/or larger data volume sizes",
                      "Common type of drive array",
                      "Simultaneously uses 2 or more hard-disk drives to achieve greater levels of performance, reliability, &/or larger data volume sizes",
                      "Mirrored drive arrayCopies of files are written to each drive in arrayDifferent parts of file are read simultaneously from different disks and “assembled” for deliverySystem is redundant (if one drive fails, file can be read from other intact drives)",
                      "Copies of files are written to each drive in arrayDifferent parts of file are read simultaneously from different disks and “assembled” for delivery",
                      "Different parts of file are read simultaneously from different disks and “assembled” for delivery",
                      "System is redundant (if one drive fails, file can be read from other intact drives)"
                    ]
                  },
                  {
                    "text": "\"Cloud\" storage systemData is saved (via Internet connection) to off-site storage system maintained by third-party providerData can be retrieved from same or different location or device, as long as it also has Internet access",
                    "sub_points": [
                      "Data is saved (via Internet connection) to off-site storage system maintained by third-party provider",
                      "Data can be retrieved from same or different location or device, as long as it also has Internet access"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Databases: Relational, Flat File, Hierarchical, and Object-Oriented": {
            "name": "Databases: Relational, Flat File, Hierarchical, and Object-Oriented",
            "url": "https://app.pathprimer.com/document/15bf292d-b9f5-4055-b859-80a7bfccebbd/lesson/bb7d05fb-2cf8-468e-97df-e92fe85d3b91",
            "content": {
              "KEY CONCEPTS": {
                "Laboratory Informatics": [
                  {
                    "text": "Databases are structured collections of records comprising data fieldsBuilding blocks of information systems",
                    "sub_points": [
                      "Building blocks of information systems"
                    ]
                  },
                  {
                    "text": "3 types of databases: Relational, hierarchical, and flat file"
                  }
                ]
              },
              "LABORATORY INFORMATICS": {
                "Databases": [
                  {
                    "text": "Database: Structured collection of records comprising data fieldsRelational database: Data organized in tablesTables are related by single field (primary key) between common fieldsIn table, each record (row) contains unique instance of data for fields (columns)\"Relational Database Structure\" gives simplified example of relational database for clinical laboratory data, comprising 4 linked tablesPatient RegistrationTest OrderTest ResultReference RangeHierarchical database: Data organized into tree-like structure of nodesEach node can contain some identifying data, plus set of subnodes of specific typeNumber of subnodes can vary between sibling nodes at same level, but type of all \"cousins\" is identicalFlat file: Single, 2-dimensional array of data elementsSimilar to electronic spreadsheet",
                    "sub_points": [
                      "Relational database: Data organized in tablesTables are related by single field (primary key) between common fieldsIn table, each record (row) contains unique instance of data for fields (columns)\"Relational Database Structure\" gives simplified example of relational database for clinical laboratory data, comprising 4 linked tablesPatient RegistrationTest OrderTest ResultReference Range",
                      "Tables are related by single field (primary key) between common fields",
                      "In table, each record (row) contains unique instance of data for fields (columns)",
                      "\"Relational Database Structure\" gives simplified example of relational database for clinical laboratory data, comprising 4 linked tablesPatient RegistrationTest OrderTest ResultReference Range",
                      "Patient Registration",
                      "Test Order",
                      "Test Result",
                      "Reference Range",
                      "Hierarchical database: Data organized into tree-like structure of nodesEach node can contain some identifying data, plus set of subnodes of specific typeNumber of subnodes can vary between sibling nodes at same level, but type of all \"cousins\" is identical",
                      "Each node can contain some identifying data, plus set of subnodes of specific type",
                      "Number of subnodes can vary between sibling nodes at same level, but type of all \"cousins\" is identical",
                      "Flat file: Single, 2-dimensional array of data elementsSimilar to electronic spreadsheet",
                      "Similar to electronic spreadsheet"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          }
        }
      },
      "Laboratory Information Systems": {
        "name": "Laboratory Information Systems",
        "url": "https://app.pathprimer.com/lesson/8348e86d-697d-4ae9-a567-80269bfd9d3f",
        "topics": {
          "Accession Number and Order Entry": {
            "name": "Accession Number and Order Entry",
            "url": "https://app.pathprimer.com/document/0b622eb0-be68-46fa-a159-ffd1210d53fe/lesson/8348e86d-697d-4ae9-a567-80269bfd9d3f",
            "content": {
              "KEY CONCEPTS": {
                "Laboratory Informatics": [
                  {
                    "text": "When samples are collected to perform laboratory tests, LIS assigns unique specimen number, commonly known as accession number, to particular order"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Laboratory information system (LIS)"
                  }
                ]
              },
              "LABORATORY INFORMATICS": {
                "Accession Number": [
                  {
                    "text": "When samples are collected to perform laboratory tests, LIS assigns unique specimen number, commonly known as accession number, to particular order"
                  },
                  {
                    "text": "Accession numbering scheme may identify each container/tube specifically, or it may identify all tests on order"
                  },
                  {
                    "text": "LIS automatically places orders on collection list (e.g., phlebotomy) for next scheduled collection"
                  }
                ],
                "Order Entry": [
                  {
                    "text": "Order entry interface exists between clinical information system and LIS"
                  },
                  {
                    "text": "Ordering physicians specify desired tests in ordering system"
                  },
                  {
                    "text": "Results ensured by interface specifications between ordering system and LISAppropriate test names or codes are available in order entry system for choosing by ordering clinicianOrders cross interface and are filed in LIS correctly, based on matching or translation of test codes between those existing in order entry system and those in LIS dictionaries",
                    "sub_points": [
                      "Appropriate test names or codes are available in order entry system for choosing by ordering clinician",
                      "Orders cross interface and are filed in LIS correctly, based on matching or translation of test codes between those existing in order entry system and those in LIS dictionaries"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Laboratory Information Systems Functions, Interfaces, and Maintenance Tables": {
            "name": "Laboratory Information Systems Functions, Interfaces, and Maintenance Tables",
            "url": "https://app.pathprimer.com/document/3b4db84c-9358-4422-9dad-a6e0b78ae2a6/lesson/8348e86d-697d-4ae9-a567-80269bfd9d3f",
            "content": {
              "KEY CONCEPTS": {
                "Laboratory Informatics": [
                  {
                    "text": "LIS consists of interrelated software programs and hardware that provide electronic data processing and information management functions necessary to support laboratory operations"
                  },
                  {
                    "text": "LIS has functionality in all phases of laboratory workflow: Preanalytic, analytic, and postanalytic"
                  },
                  {
                    "text": "LIS interfaces allow transformation of electronic information between otherwise incompatible systems"
                  },
                  {
                    "text": "LIS maintenance tables standardize terms and definitions in laboratory operations"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Admission/discharge/transfer (ADT)"
                  },
                  {
                    "text": "Electronic medical record (EMR)"
                  },
                  {
                    "text": "Laboratory information system (LIS)"
                  }
                ]
              },
              "LABORATORY INFORMATICS": {
                "Laboratory Information Systems": [
                  {
                    "text": "LIS consists of interrelated software programs and hardware that provide electronic data processing and information management functions necessary to support laboratory operations"
                  },
                  {
                    "text": "LIS can support clinical pathology, anatomic pathology, or both"
                  },
                  {
                    "text": "FunctionsPreanalyticTest order creation: Request may be electronic or paper-basedIf paper-based, it needs to be entered into LISSpecimen collection: Different scenarios managed by LIS include inpatient versus outpatient and STAT versus routineSpecimen receipt: Includes specimen tracking and test status communicationAnalyticSpecimen and test distributionAfter specimen is received and test orders are entered into LIS, each test order is filed in databaseIf applicable, LIS generates and tracks labels for aliquotsAnalysis/interpretation: Analyzer performs tests according to orders downloaded from LISAdditional testing: Reflex testing involves automatic generation of new test if initial results fulfill predefined criteriaResult entry: Results uploaded to LISPostanalyticResult reporting: Can be printed or transmitted to EMRCorrected reportsLIS can issue new reports if previously reported results include error that must be changedNew result must be clearly identified as new report",
                    "sub_points": [
                      "PreanalyticTest order creation: Request may be electronic or paper-basedIf paper-based, it needs to be entered into LISSpecimen collection: Different scenarios managed by LIS include inpatient versus outpatient and STAT versus routineSpecimen receipt: Includes specimen tracking and test status communication",
                      "Test order creation: Request may be electronic or paper-basedIf paper-based, it needs to be entered into LIS",
                      "If paper-based, it needs to be entered into LIS",
                      "Specimen collection: Different scenarios managed by LIS include inpatient versus outpatient and STAT versus routine",
                      "Specimen receipt: Includes specimen tracking and test status communication",
                      "AnalyticSpecimen and test distributionAfter specimen is received and test orders are entered into LIS, each test order is filed in databaseIf applicable, LIS generates and tracks labels for aliquotsAnalysis/interpretation: Analyzer performs tests according to orders downloaded from LISAdditional testing: Reflex testing involves automatic generation of new test if initial results fulfill predefined criteriaResult entry: Results uploaded to LIS",
                      "Specimen and test distributionAfter specimen is received and test orders are entered into LIS, each test order is filed in databaseIf applicable, LIS generates and tracks labels for aliquots",
                      "After specimen is received and test orders are entered into LIS, each test order is filed in database",
                      "If applicable, LIS generates and tracks labels for aliquots",
                      "Analysis/interpretation: Analyzer performs tests according to orders downloaded from LIS",
                      "Additional testing: Reflex testing involves automatic generation of new test if initial results fulfill predefined criteria",
                      "Result entry: Results uploaded to LIS",
                      "PostanalyticResult reporting: Can be printed or transmitted to EMRCorrected reportsLIS can issue new reports if previously reported results include error that must be changedNew result must be clearly identified as new report",
                      "Result reporting: Can be printed or transmitted to EMR",
                      "Corrected reportsLIS can issue new reports if previously reported results include error that must be changedNew result must be clearly identified as new report",
                      "LIS can issue new reports if previously reported results include error that must be changed",
                      "New result must be clearly identified as new report"
                    ]
                  },
                  {
                    "text": "Interfaces: Software and hardware connections that translate electronic messages so that otherwise incompatible systems can exchange dataApplication interfaces: Interfaces to other computer systemsFor data exchange between laboratory and outside worldExamplesElectronic medical record, order entry, result reporting, ADT, laboratory web portal, billing, pharmacy, emergency department, operating room, tumor registry, public health agenciesInstrument (device) interfaces: Integral to laboratory operations and data flowExamplesAutomated analyzers, middleware, lab automation systems, point-of-care testing devices, patient ID systems, tissue cassette and slide engravers, immunohistochemistry stainers, printers/fax machines",
                    "sub_points": [
                      "Application interfaces: Interfaces to other computer systemsFor data exchange between laboratory and outside worldExamplesElectronic medical record, order entry, result reporting, ADT, laboratory web portal, billing, pharmacy, emergency department, operating room, tumor registry, public health agencies",
                      "For data exchange between laboratory and outside world",
                      "ExamplesElectronic medical record, order entry, result reporting, ADT, laboratory web portal, billing, pharmacy, emergency department, operating room, tumor registry, public health agencies",
                      "Electronic medical record, order entry, result reporting, ADT, laboratory web portal, billing, pharmacy, emergency department, operating room, tumor registry, public health agencies",
                      "Instrument (device) interfaces: Integral to laboratory operations and data flowExamplesAutomated analyzers, middleware, lab automation systems, point-of-care testing devices, patient ID systems, tissue cassette and slide engravers, immunohistochemistry stainers, printers/fax machines",
                      "ExamplesAutomated analyzers, middleware, lab automation systems, point-of-care testing devices, patient ID systems, tissue cassette and slide engravers, immunohistochemistry stainers, printers/fax machines",
                      "Automated analyzers, middleware, lab automation systems, point-of-care testing devices, patient ID systems, tissue cassette and slide engravers, immunohistochemistry stainers, printers/fax machines"
                    ]
                  },
                  {
                    "text": "LIS maintenance tables (or dictionaries)﻿Data tables in LIS database that determine structure, rules, formats, entity names, and conventions for information processing throughout laboratoryEntries in LIS maintenance tables establish data definitions for all data elements and entities processed in laboratoryThey essentially define people, places, and things in LISExamplesTest definitions, worksheets and logs, persons (users), user type (access privileges), container type, specimen type, patient location, laboratory department, autoverification parameters",
                    "sub_points": [
                      "Data tables in LIS database that determine structure, rules, formats, entity names, and conventions for information processing throughout laboratory",
                      "Entries in LIS maintenance tables establish data definitions for all data elements and entities processed in laboratory",
                      "They essentially define people, places, and things in LIS",
                      "ExamplesTest definitions, worksheets and logs, persons (users), user type (access privileges), container type, specimen type, patient location, laboratory department, autoverification parameters",
                      "Test definitions, worksheets and logs, persons (users), user type (access privileges), container type, specimen type, patient location, laboratory department, autoverification parameters"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Coding Standards": {
            "name": "Coding Standards",
            "url": "https://app.pathprimer.com/document/19f8815f-ca1e-4500-b15f-f5eb573ded4b/lesson/8348e86d-697d-4ae9-a567-80269bfd9d3f",
            "content": {
              "KEY CONCEPTS": {
                "Laboratory Informatics": [
                  {
                    "text": "Coding standards provide controlled terminology or finite set of terms with agreed-upon meaning, which allows users to communicate information with confidence that receiver will be able to interpret unambiguously"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Current Procedural Terminology (CPT)"
                  },
                  {
                    "text": "Health Level 7 (HL7)"
                  },
                  {
                    "text": "International Classification of Diseases (ICD)"
                  },
                  {
                    "text": "Logical Observation Identifiers Names and Codes (LOINC)"
                  }
                ]
              },
              "LABORATORY INFORMATICS": {
                "Coding (or Communication) Standards": [
                  {
                    "text": "Provides controlled terminology or finite set of terms with agreed-upon meaningAllows users to communicate information with confidence that receiver will be able to interpret unambiguously",
                    "sub_points": [
                      "Allows users to communicate information with confidence that receiver will be able to interpret unambiguously"
                    ]
                  },
                  {
                    "text": "Using conventions and definitions to standardize information exchange between different systems is less complex and time-consuming strategy than creating custom interfaces between applications"
                  },
                  {
                    "text": "Common coding systemsICDContains set of terms primarily devoted to describing medical conditionsTypically required to be used in electronic billing transactions along with CPT code describing service renderedHL7Protocol for electronic data exchange that specifies syntax and rules for messagingLOINCSet of universal, identified for laboratory, test code data fields with HL7 messages and databasesA fully specified name of a test result or clinical observation has 5 to 6 major parts (See Table 1)",
                    "sub_points": [
                      "ICDContains set of terms primarily devoted to describing medical conditionsTypically required to be used in electronic billing transactions along with CPT code describing service rendered",
                      "Contains set of terms primarily devoted to describing medical conditions",
                      "Typically required to be used in electronic billing transactions along with CPT code describing service rendered",
                      "HL7Protocol for electronic data exchange that specifies syntax and rules for messaging",
                      "Protocol for electronic data exchange that specifies syntax and rules for messaging",
                      "LOINCSet of universal, identified for laboratory, test code data fields with HL7 messages and databases",
                      "Set of universal, identified for laboratory, test code data fields with HL7 messages and databases",
                      "A fully specified name of a test result or clinical observation has 5 to 6 major parts (See Table 1)"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Middleware": {
            "name": "Middleware",
            "url": "https://app.pathprimer.com/document/c39c4992-8eca-4d21-8085-cfe8382f7125/lesson/8348e86d-697d-4ae9-a567-80269bfd9d3f",
            "content": {
              "KEY CONCEPTS": {
                "Terminology": [
                  {
                    "text": "Middleware is software that provides link or bridge between separate software applications"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Definitions": [
                  {
                    "text": "Middleware is software that provides link or bridge between separate software applicationsTypically, middleware resides between application software and operating systemsAllows multiple processes running on 1 or several computers to interact with each otherOverall goal is to provide interoperability, adaptiveness, and reconfigurability",
                    "sub_points": [
                      "Typically, middleware resides between application software and operating systems",
                      "Allows multiple processes running on 1 or several computers to interact with each other",
                      "Overall goal is to provide interoperability, adaptiveness, and reconfigurability"
                    ]
                  },
                  {
                    "text": "Types of middlewareMessage-oriented middlewareTransitions or event notifications are delivered between disparate systems using messages (to mailbox)Messages sent to client are collected and stored until executedDatabase middlewareEnables applications to connect and communicate with 1 or more local or remote databasesAlso allows for direct access to database structuresDoes not offer 2-way communication between servers and clientsApplication server middlewareWeb-based application server that provides interfaces to spectrum of applications, including legacy systemsTransactional (or transaction processing) monitorSupports distributed synchronous transactionsCoordinates requests between clients and serversRemote procedure callProvides calling procedure on remote systemsAllows for synchronous interactions between systemsObject middlewareProvides object components that can be accessed across network to perform services",
                    "sub_points": [
                      "Message-oriented middlewareTransitions or event notifications are delivered between disparate systems using messages (to mailbox)Messages sent to client are collected and stored until executed",
                      "Transitions or event notifications are delivered between disparate systems using messages (to mailbox)",
                      "Messages sent to client are collected and stored until executed",
                      "Database middlewareEnables applications to connect and communicate with 1 or more local or remote databasesAlso allows for direct access to database structuresDoes not offer 2-way communication between servers and clients",
                      "Enables applications to connect and communicate with 1 or more local or remote databases",
                      "Also allows for direct access to database structures",
                      "Does not offer 2-way communication between servers and clients",
                      "Application server middlewareWeb-based application server that provides interfaces to spectrum of applications, including legacy systems",
                      "Web-based application server that provides interfaces to spectrum of applications, including legacy systems",
                      "Transactional (or transaction processing) monitorSupports distributed synchronous transactionsCoordinates requests between clients and servers",
                      "Supports distributed synchronous transactions",
                      "Coordinates requests between clients and servers",
                      "Remote procedure callProvides calling procedure on remote systemsAllows for synchronous interactions between systems",
                      "Provides calling procedure on remote systems",
                      "Allows for synchronous interactions between systems",
                      "Object middlewareProvides object components that can be accessed across network to perform services",
                      "Provides object components that can be accessed across network to perform services"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Service Agreements and Application Service Provider Model": {
            "name": "Service Agreements and Application Service Provider Model",
            "url": "https://app.pathprimer.com/document/93ea710e-3853-453f-b93c-1423cbdeae40/lesson/8348e86d-697d-4ae9-a567-80269bfd9d3f",
            "content": {
              "KEY CONCEPTS": {
                "Terminology": [
                  {
                    "text": "Application service provider model is way for laboratory to implement its LIS &/or web portal system"
                  },
                  {
                    "text": "Service level agreement is typically part of contract when ASP model is used"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Application service provider (ASP)"
                  },
                  {
                    "text": "Information technology (IT)"
                  },
                  {
                    "text": "Laboratory information system (LIS)"
                  },
                  {
                    "text": "Service level agreement (SLA)"
                  }
                ],
                "Definitions": [
                  {
                    "text": "ASP modelMethod for laboratory to implement its LIS &/or web portal systemBoth IT architecture and contractual agreementLIS vendor or independent service provider provides LIS application or suite of services to laboratory over network from remote site in exchange for recurring feeManagement of LIS infrastructure is outsourcedSome functions are managed entirely by service provider and hosted at data center remote from laboratoryHardware, ﻿﻿﻿﻿system software, ﻿security, upgrades, and other maintenance functions, as well as data center functions﻿",
                    "sub_points": [
                      "Method for laboratory to implement its LIS &/or web portal system",
                      "Both IT architecture and contractual agreement",
                      "LIS vendor or independent service provider provides LIS application or suite of services to laboratory over network from remote site in exchange for recurring feeManagement of LIS infrastructure is outsourcedSome functions are managed entirely by service provider and hosted at data center remote from laboratoryHardware, ﻿﻿﻿﻿system software, ﻿security, upgrades, and other maintenance functions, as well as data center functions﻿",
                      "Management of LIS infrastructure is outsourced",
                      "Some functions are managed entirely by service provider and hosted at data center remote from laboratoryHardware, ﻿﻿﻿﻿system software, ﻿security, upgrades, and other maintenance functions, as well as data center functions﻿",
                      "Hardware, ﻿﻿﻿﻿system software, ﻿security, upgrades, and other maintenance functions, as well as data center functions﻿"
                    ]
                  },
                  {
                    "text": "SLATypically part of contract when ASP model is usedSLA defines technical and business parameters of relationship between ASP vendor and laboratoryOutlines responsibilities of IT service provider and clientDefines quantifiable metrics and targets for system reliability, response time, and uptimeWill outline how problems that arise are addressed",
                    "sub_points": [
                      "Typically part of contract when ASP model is used",
                      "SLA defines technical and business parameters of relationship between ASP vendor and laboratoryOutlines responsibilities of IT service provider and clientDefines quantifiable metrics and targets for system reliability, response time, and uptimeWill outline how problems that arise are addressed",
                      "Outlines responsibilities of IT service provider and client",
                      "Defines quantifiable metrics and targets for system reliability, response time, and uptime",
                      "Will outline how problems that arise are addressed"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Data Field": {
            "name": "Data Field",
            "url": "https://app.pathprimer.com/document/0d0ffb11-f8d7-4dfb-976f-c5fda1a4c870/lesson/8348e86d-697d-4ae9-a567-80269bfd9d3f",
            "content": {
              "TERMINOLOGY": {
                "Definitions": [
                  {
                    "text": "Database: Nonvolatile structured collection of similar information about variable number of instances of some entity"
                  },
                  {
                    "text": "Record: Each instance of entity"
                  },
                  {
                    "text": "Field: Each item of information stored for entityType of data needs to be assigned to field based on values that will be enteredExamplesTextNumberDateTimeField's data type determines other important field qualitiesHow field can be used in expressionsMaximum size of field valueWhether field can be indexedWhich formats can be used with fieldUse of field types performs basic form of validation",
                    "sub_points": [
                      "Type of data needs to be assigned to field based on values that will be enteredExamplesTextNumberDateTime",
                      "ExamplesTextNumberDateTime",
                      "Text",
                      "Number",
                      "Date",
                      "Time",
                      "Field's data type determines other important field qualitiesHow field can be used in expressionsMaximum size of field valueWhether field can be indexedWhich formats can be used with field",
                      "How field can be used in expressions",
                      "Maximum size of field value",
                      "Whether field can be indexed",
                      "Which formats can be used with field",
                      "Use of field types performs basic form of validation"
                    ]
                  },
                  {
                    "text": "Value: Specific data element"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Health Care Information Systems": {
            "name": "Health Care Information Systems",
            "url": "https://app.pathprimer.com/document/d358baed-3422-4ca1-b16e-da52ecc6554b/lesson/8348e86d-697d-4ae9-a567-80269bfd9d3f",
            "content": {
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Admission-discharge-transfer (ADT)"
                  },
                  {
                    "text": "Electronic data repository (EDR)"
                  },
                  {
                    "text": "Electronic data warehouse (EDW)"
                  },
                  {
                    "text": "Electronic medical record (EMR)"
                  },
                  {
                    "text": "Health information system (HIS)"
                  },
                  {
                    "text": "Information systems (IS)"
                  },
                  {
                    "text": "Laboratory information system (LIS)"
                  }
                ]
              },
              "LABORATORY INFORMATICS": {
                "﻿Health Care Enterprise Information Systems﻿": [
                  {
                    "text": "ADT, HIS, LIS, EMR, EDR, EDW, and billing are most common types of IS in health care setting"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Laboratory Automation Systems": {
            "name": "Laboratory Automation Systems",
            "url": "https://app.pathprimer.com/document/9ae9e26b-6f83-421e-a007-603bbce8566d/lesson/8348e86d-697d-4ae9-a567-80269bfd9d3f",
            "content": {
              "KEY CONCEPTS": {
                "Terminology": [
                  {
                    "text": "In laboratory, automation systems electronically transfer, analyze, and process information related to diagnostic testing of patient specimens, controls, calibrators, standards, and images"
                  },
                  {
                    "text": "Automation has been applied to preanalytic, analytic, and postanalytic stages of laboratory testing"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Laboratory information system (LIS)"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Automation: Use of automated equipment and information technology for manufacturing or production processIn laboratory, automation systems electronically transfer, analyze, and process information related to diagnostic testing of patient specimens, controls, calibrators, standards, and imagesIntended to reduce need for human work in this processAdvantagesIncreased productivityImproved turnaround timeReduction of exposure to hazards for lab employeesDisadvantagesInitial cost of investmentRisk of downtimeNeed for highly technical personnel",
                    "sub_points": [
                      "In laboratory, automation systems electronically transfer, analyze, and process information related to diagnostic testing of patient specimens, controls, calibrators, standards, and imagesIntended to reduce need for human work in this process",
                      "Intended to reduce need for human work in this process",
                      "AdvantagesIncreased productivityImproved turnaround timeReduction of exposure to hazards for lab employees",
                      "Increased productivity",
                      "Improved turnaround time",
                      "Reduction of exposure to hazards for lab employees",
                      "DisadvantagesInitial cost of investmentRisk of downtimeNeed for highly technical personnel",
                      "Initial cost of investment",
                      "Risk of downtime",
                      "Need for highly technical personnel"
                    ]
                  },
                  {
                    "text": "Automation has been applied to preanalytic, analytic, and postanalytic stages of laboratory testingPreanalytic: Specimen transportation and sample processingAnalytic: Producing test dataRequires tubes directly placed onto instrumentsDigital imaging may be utilizedRecognizing specimens and sample materialPerforming volume calculationsInstruments may have unidirectional or bidirectional interfacesUnidirectional: Lab technologist has to manually enter test orders on device; after analysis, results get transmitted electronically to LISBidirectional: LIS transmits test order to device and also receives final resultsAutoverification: Automatic review and release of results from instrument without technologist review, after applying rule-based logic that allows communication between instruments to generate an action based on set of predefined rules or algorithmsPostanalytic: Delivery of diagnostic information to health care providers and storage of specimens",
                    "sub_points": [
                      "Preanalytic: Specimen transportation and sample processing",
                      "Analytic: Producing test dataRequires tubes directly placed onto instrumentsDigital imaging may be utilizedRecognizing specimens and sample materialPerforming volume calculationsInstruments may have unidirectional or bidirectional interfacesUnidirectional: Lab technologist has to manually enter test orders on device; after analysis, results get transmitted electronically to LISBidirectional: LIS transmits test order to device and also receives final resultsAutoverification: Automatic review and release of results from instrument without technologist review, after applying rule-based logic that allows communication between instruments to generate an action based on set of predefined rules or algorithms",
                      "Requires tubes directly placed onto instruments",
                      "Digital imaging may be utilizedRecognizing specimens and sample materialPerforming volume calculations",
                      "Recognizing specimens and sample material",
                      "Performing volume calculations",
                      "Instruments may have unidirectional or bidirectional interfacesUnidirectional: Lab technologist has to manually enter test orders on device; after analysis, results get transmitted electronically to LISBidirectional: LIS transmits test order to device and also receives final results",
                      "Unidirectional: Lab technologist has to manually enter test orders on device; after analysis, results get transmitted electronically to LIS",
                      "Bidirectional: LIS transmits test order to device and also receives final results",
                      "Autoverification: Automatic review and release of results from instrument without technologist review, after applying rule-based logic that allows communication between instruments to generate an action based on set of predefined rules or algorithms",
                      "Postanalytic: Delivery of diagnostic information to health care providers and storage of specimens"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          }
        }
      }
    }
  }
}